id	sid	tid	token	lemma	pos
ajlm-916	1	1	abstract	abstract	ADJ
ajlm-916	1	2	introduction	introduction	NOUN
ajlm-916	1	3	ethical	ethical	ADJ
ajlm-916	1	4	considerations	consideration	NOUN
ajlm-916	1	5	case	case	NOUN
ajlm-916	1	6	presentation	presentation	NOUN
ajlm-916	1	7	management	management	NOUN
ajlm-916	1	8	and	and	CCONJ
ajlm-916	1	9	outcomes	outcome	NOUN
ajlm-916	1	10	discussion	discussion	NOUN
ajlm-916	1	11	acknowledgements	acknowledgement	NOUN
ajlm-916	1	12	references	reference	NOUN
ajlm-916	1	13	about	about	ADP
ajlm-916	1	14	the	the	DET
ajlm-916	1	15	author(s	author(s	NOUN
ajlm-916	1	16	)	)	PUNCT
ajlm-916	1	17	mpho	mpho	PROPN
ajlm-916	1	18	l.	l.	PROPN
ajlm-916	1	19	sikhosana	sikhosana	PROPN
ajlm-916	1	20	south	south	PROPN
ajlm-916	1	21	african	african	ADJ
ajlm-916	1	22	field	field	NOUN
ajlm-916	1	23	epidemiology	epidemiology	NOUN
ajlm-916	1	24	training	training	NOUN
ajlm-916	1	25	programme	programme	NOUN
ajlm-916	1	26	,	,	PUNCT
ajlm-916	1	27	national	national	PROPN
ajlm-916	1	28	institute	institute	NOUN
ajlm-916	1	29	for	for	ADP
ajlm-916	1	30	communicable	communicable	NOUN
ajlm-916	1	31	diseases	disease	NOUN
ajlm-916	1	32	,	,	PUNCT
ajlm-916	1	33	division	division	NOUN
ajlm-916	1	34	of	of	ADP
ajlm-916	1	35	national	national	PROPN
ajlm-916	1	36	health	health	PROPN
ajlm-916	1	37	laboratory	laboratory	PROPN
ajlm-916	1	38	services	services	PROPN
ajlm-916	1	39	,	,	PUNCT
ajlm-916	1	40	johannesburg	johannesburg	PROPN
ajlm-916	1	41	,	,	PUNCT
ajlm-916	1	42	south	south	PROPN
ajlm-916	1	43	africa	africa	PROPN
ajlm-916	1	44	asma	asma	PROPN
ajlm-916	1	45	salloo	salloo	PROPN
ajlm-916	1	46	department	department	PROPN
ajlm-916	1	47	of	of	ADP
ajlm-916	1	48	critical	critical	ADJ
ajlm-916	1	49	care	care	NOUN
ajlm-916	1	50	,	,	PUNCT
ajlm-916	1	51	chris	chris	PROPN
ajlm-916	1	52	hani	hani	PROPN
ajlm-916	1	53	baragwanath	baragwanath	PROPN
ajlm-916	1	54	academic	academic	ADJ
ajlm-916	1	55	hospital	hospital	PROPN
ajlm-916	1	56	,	,	PUNCT
ajlm-916	1	57	soweto	soweto	PROPN
ajlm-916	1	58	,	,	PUNCT
ajlm-916	1	59	south	south	PROPN
ajlm-916	1	60	africa	africa	PROPN
ajlm-916	1	61	department	department	PROPN
ajlm-916	1	62	of	of	ADP
ajlm-916	1	63	critical	critical	ADJ
ajlm-916	1	64	care	care	NOUN
ajlm-916	1	65	,	,	PUNCT
ajlm-916	1	66	university	university	NOUN
ajlm-916	1	67	of	of	ADP
ajlm-916	1	68	witwatersrand	witwatersrand	PROPN
ajlm-916	1	69	,	,	PUNCT
ajlm-916	1	70	johannesburg	johannesburg	PROPN
ajlm-916	1	71	,	,	PUNCT
ajlm-916	1	72	south	south	PROPN
ajlm-916	1	73	africa	africa	PROPN
ajlm-916	1	74	monica	monica	PROPN
ajlm-916	1	75	birkhead	birkhead	PROPN
ajlm-916	1	76	centre	centre	NOUN
ajlm-916	1	77	for	for	ADP
ajlm-916	1	78	emerging	emerge	VERB
ajlm-916	1	79	zoonotic	zoonotic	ADJ
ajlm-916	1	80	and	and	CCONJ
ajlm-916	1	81	parasitic	parasitic	ADJ
ajlm-916	1	82	diseases	disease	NOUN
ajlm-916	1	83	,	,	PUNCT
ajlm-916	1	84	national	national	PROPN
ajlm-916	1	85	institute	institute	NOUN
ajlm-916	1	86	for	for	ADP
ajlm-916	1	87	communicable	communicable	NOUN
ajlm-916	1	88	diseases	disease	NOUN
ajlm-916	1	89	,	,	PUNCT
ajlm-916	1	90	division	division	NOUN
ajlm-916	1	91	of	of	ADP
ajlm-916	1	92	national	national	PROPN
ajlm-916	1	93	health	health	PROPN
ajlm-916	1	94	laboratory	laboratory	PROPN
ajlm-916	1	95	services	services	PROPN
ajlm-916	1	96	,	,	PUNCT
ajlm-916	1	97	johannesburg	johannesburg	PROPN
ajlm-916	1	98	,	,	PUNCT
ajlm-916	1	99	south	south	PROPN
ajlm-916	1	100	africa	africa	PROPN
ajlm-916	1	101	kerrigan	kerrigan	VERB
ajlm-916	1	102	mccarthy	mccarthy	PROPN
ajlm-916	1	103	division	division	NOUN
ajlm-916	1	104	for	for	ADP
ajlm-916	1	105	public	public	ADJ
ajlm-916	1	106	health	health	NOUN
ajlm-916	1	107	surveillance	surveillance	NOUN
ajlm-916	1	108	and	and	CCONJ
ajlm-916	1	109	response	response	NOUN
ajlm-916	1	110	,	,	PUNCT
ajlm-916	1	111	national	national	PROPN
ajlm-916	1	112	institute	institute	NOUN
ajlm-916	1	113	for	for	ADP
ajlm-916	1	114	communicable	communicable	NOUN
ajlm-916	1	115	diseases	disease	NOUN
ajlm-916	1	116	,	,	PUNCT
ajlm-916	1	117	division	division	NOUN
ajlm-916	1	118	of	of	ADP
ajlm-916	1	119	national	national	PROPN
ajlm-916	1	120	health	health	PROPN
ajlm-916	1	121	laboratory	laboratory	PROPN
ajlm-916	1	122	services	services	PROPN
ajlm-916	1	123	,	,	PUNCT
ajlm-916	1	124	johannesburg	johannesburg	PROPN
ajlm-916	1	125	,	,	PUNCT
ajlm-916	1	126	south	south	PROPN
ajlm-916	1	127	africa	africa	PROPN
ajlm-916	1	128	citation	citation	PROPN
ajlm-916	1	129	sikhosana	sikhosana	PROPN
ajlm-916	1	130	ml	ml	PROPN
ajlm-916	1	131	,	,	PUNCT
ajlm-916	1	132	salloo	salloo	VERB
ajlm-916	1	133	a	a	DET
ajlm-916	1	134	,	,	PUNCT
ajlm-916	1	135	birkhead	birkhead	PROPN
ajlm-916	1	136	m	m	PROPN
ajlm-916	1	137	,	,	PUNCT
ajlm-916	1	138	mccarthy	mccarthy	PROPN
ajlm-916	1	139	k.	k.	PROPN
ajlm-916	1	140	atypical	atypical	ADJ
ajlm-916	1	141	presentation	presentation	NOUN
ajlm-916	1	142	of	of	ADP
ajlm-916	1	143	herpes	herpe	NOUN
ajlm-916	1	144	simplex	simplex	NOUN
ajlm-916	1	145	virus	virus	NOUN
ajlm-916	1	146	type	type	NOUN
ajlm-916	1	147	1	1	NUM
ajlm-916	1	148	infection	infection	NOUN
ajlm-916	1	149	in	in	ADP
ajlm-916	1	150	paediatric	paediatric	ADJ
ajlm-916	1	151	burns	burn	NOUN
ajlm-916	1	152	patients	patient	NOUN
ajlm-916	1	153	in	in	ADP
ajlm-916	1	154	a	a	DET
ajlm-916	1	155	large	large	ADJ
ajlm-916	1	156	tertiary	tertiary	ADJ
ajlm-916	1	157	hospital	hospital	NOUN
ajlm-916	1	158	,	,	PUNCT
ajlm-916	1	159	south	south	PROPN
ajlm-916	1	160	africa	africa	PROPN
ajlm-916	1	161	.	.	PUNCT
ajlm-916	2	1	afr	afr	PROPN
ajlm-916	2	2	j	j	PROPN
ajlm-916	2	3	lab	lab	PROPN
ajlm-916	2	4	med	med	PROPN
ajlm-916	2	5	.	.	PUNCT
ajlm-916	2	6	2019;8(1	2019;8(1	NOUN
ajlm-916	2	7	)	)	PUNCT
ajlm-916	2	8	,	,	PUNCT
ajlm-916	2	9	a916	a916	PROPN
ajlm-916	2	10	.	.	PUNCT
ajlm-916	2	11	https://doi.org/10.4102/ajlm.v8i1.916	https://doi.org/10.4102/ajlm.v8i1.916	PROPN
ajlm-916	2	12	case	case	NOUN
ajlm-916	2	13	study	study	VERB
ajlm-916	2	14	atypical	atypical	ADJ
ajlm-916	2	15	presentation	presentation	NOUN
ajlm-916	2	16	of	of	ADP
ajlm-916	2	17	herpes	herpe	NOUN
ajlm-916	2	18	simplex	simplex	NOUN
ajlm-916	2	19	virus	virus	NOUN
ajlm-916	2	20	type	type	NOUN
ajlm-916	2	21	1	1	NUM
ajlm-916	2	22	infection	infection	NOUN
ajlm-916	2	23	in	in	ADP
ajlm-916	2	24	paediatric	paediatric	ADJ
ajlm-916	2	25	burns	burn	NOUN
ajlm-916	2	26	patients	patient	NOUN
ajlm-916	2	27	in	in	ADP
ajlm-916	2	28	a	a	DET
ajlm-916	2	29	large	large	ADJ
ajlm-916	2	30	tertiary	tertiary	ADJ
ajlm-916	2	31	hospital	hospital	NOUN
ajlm-916	2	32	,	,	PUNCT
ajlm-916	2	33	south	south	PROPN
ajlm-916	2	34	africa	africa	PROPN
ajlm-916	2	35	mpho	mpho	PROPN
ajlm-916	2	36	l.	l.	PROPN
ajlm-916	2	37	sikhosana	sikhosana	PROPN
ajlm-916	2	38	,	,	PUNCT
ajlm-916	2	39	asma	asma	PROPN
ajlm-916	2	40	salloo	salloo	PROPN
ajlm-916	2	41	,	,	PUNCT
ajlm-916	2	42	monica	monica	PROPN
ajlm-916	2	43	birkhead	birkhead	PROPN
ajlm-916	2	44	,	,	PUNCT
ajlm-916	2	45	kerrigan	kerrigan	PROPN
ajlm-916	2	46	mccarthy	mccarthy	PROPN
ajlm-916	2	47	received	receive	VERB
ajlm-916	2	48	:	:	PUNCT
ajlm-916	2	49	03	03	NUM
ajlm-916	2	50	oct	oct	PROPN
ajlm-916	2	51	.	.	PROPN
ajlm-916	2	52	2018	2018	NUM
ajlm-916	2	53	;	;	PUNCT
ajlm-916	2	54	accepted	accept	VERB
ajlm-916	2	55	:	:	PUNCT
ajlm-916	2	56	03	03	NUM
ajlm-916	2	57	sept	sept	PROPN
ajlm-916	2	58	.	.	PROPN
ajlm-916	2	59	2019	2019	NUM
ajlm-916	2	60	;	;	PUNCT
ajlm-916	2	61	published	publish	VERB
ajlm-916	2	62	:	:	PUNCT
ajlm-916	2	63	23	23	NUM
ajlm-916	2	64	oct	oct	NOUN
ajlm-916	2	65	.	.	PROPN
ajlm-916	2	66	2019	2019	NUM
ajlm-916	2	67	copyright	copyright	NOUN
ajlm-916	2	68	:	:	PUNCT
ajlm-916	2	69	©	©	PROPN
ajlm-916	2	70	2019	2019	NUM
ajlm-916	2	71	.	.	PUNCT
ajlm-916	3	1	the	the	DET
ajlm-916	3	2	author(s	author(s	PROPN
ajlm-916	3	3	)	)	PUNCT
ajlm-916	3	4	.	.	PUNCT
ajlm-916	4	1	licensee	licensee	NOUN
ajlm-916	4	2	:	:	PUNCT
ajlm-916	4	3	aosis	aosis	NOUN
ajlm-916	4	4	.	.	PUNCT
ajlm-916	5	1	this	this	PRON
ajlm-916	5	2	is	be	AUX
ajlm-916	5	3	an	an	DET
ajlm-916	5	4	open	open	ADJ
ajlm-916	5	5	access	access	NOUN
ajlm-916	5	6	article	article	NOUN
ajlm-916	5	7	distributed	distribute	VERB
ajlm-916	5	8	under	under	ADP
ajlm-916	5	9	the	the	DET
ajlm-916	5	10	terms	term	NOUN
ajlm-916	5	11	of	of	ADP
ajlm-916	5	12	the	the	DET
ajlm-916	5	13	creative	creative	ADJ
ajlm-916	5	14	commons	common	NOUN
ajlm-916	5	15	attribution	attribution	NOUN
ajlm-916	5	16	license	license	NOUN
ajlm-916	5	17	,	,	PUNCT
ajlm-916	5	18	which	which	PRON
ajlm-916	5	19	permits	permit	VERB
ajlm-916	5	20	unrestricted	unrestricted	ADJ
ajlm-916	5	21	use	use	NOUN
ajlm-916	5	22	,	,	PUNCT
ajlm-916	5	23	distribution	distribution	NOUN
ajlm-916	5	24	,	,	PUNCT
ajlm-916	5	25	and	and	CCONJ
ajlm-916	5	26	reproduction	reproduction	NOUN
ajlm-916	5	27	in	in	ADP
ajlm-916	5	28	any	any	DET
ajlm-916	5	29	medium	medium	NOUN
ajlm-916	5	30	,	,	PUNCT
ajlm-916	5	31	provided	provide	VERB
ajlm-916	5	32	the	the	DET
ajlm-916	5	33	original	original	ADJ
ajlm-916	5	34	work	work	NOUN
ajlm-916	5	35	is	be	AUX
ajlm-916	5	36	properly	properly	ADV
ajlm-916	5	37	cited	cite	VERB
ajlm-916	5	38	.	.	PUNCT
ajlm-916	6	1	abstract	abstract	ADJ
ajlm-916	6	2	introduction	introduction	NOUN
ajlm-916	6	3	:	:	PUNCT
ajlm-916	6	4	herpes	herpe	NOUN
ajlm-916	6	5	simplex	simplex	NOUN
ajlm-916	6	6	virus	virus	NOUN
ajlm-916	6	7	has	have	AUX
ajlm-916	6	8	been	be	AUX
ajlm-916	6	9	reported	report	VERB
ajlm-916	6	10	in	in	ADP
ajlm-916	6	11	the	the	DET
ajlm-916	6	12	literature	literature	NOUN
ajlm-916	6	13	to	to	PART
ajlm-916	6	14	commonly	commonly	ADV
ajlm-916	6	15	complicate	complicate	VERB
ajlm-916	6	16	burn	burn	NOUN
ajlm-916	6	17	wounds	wound	NOUN
ajlm-916	6	18	.	.	PUNCT
ajlm-916	7	1	however	however	ADV
ajlm-916	7	2	,	,	PUNCT
ajlm-916	7	3	there	there	PRON
ajlm-916	7	4	is	be	VERB
ajlm-916	7	5	paucity	paucity	NOUN
ajlm-916	7	6	of	of	ADP
ajlm-916	7	7	such	such	ADJ
ajlm-916	7	8	data	datum	NOUN
ajlm-916	7	9	in	in	ADP
ajlm-916	7	10	the	the	DET
ajlm-916	7	11	south	south	ADJ
ajlm-916	7	12	african	african	ADJ
ajlm-916	7	13	setting	setting	NOUN
ajlm-916	7	14	.	.	PUNCT
ajlm-916	8	1	case	case	NOUN
ajlm-916	8	2	presentation	presentation	NOUN
ajlm-916	8	3	:	:	PUNCT
ajlm-916	8	4	eight	eight	NUM
ajlm-916	8	5	paediatric	paediatric	ADJ
ajlm-916	8	6	burns	burn	NOUN
ajlm-916	8	7	patients	patient	NOUN
ajlm-916	8	8	with	with	ADP
ajlm-916	8	9	ages	age	NOUN
ajlm-916	8	10	ranging	range	VERB
ajlm-916	8	11	between	between	ADP
ajlm-916	8	12	10	10	NUM
ajlm-916	8	13	months	month	NOUN
ajlm-916	8	14	and	and	CCONJ
ajlm-916	8	15	5	5	NUM
ajlm-916	8	16	years	year	NOUN
ajlm-916	8	17	presented	present	VERB
ajlm-916	8	18	with	with	ADP
ajlm-916	8	19	a	a	DET
ajlm-916	8	20	febrile	febrile	NOUN
ajlm-916	8	21	maculopapular	maculopapular	ADJ
ajlm-916	8	22	rash	rash	ADJ
ajlm-916	8	23	illness	illness	NOUN
ajlm-916	8	24	in	in	ADP
ajlm-916	8	25	a	a	DET
ajlm-916	8	26	paediatric	paediatric	ADJ
ajlm-916	8	27	ward	ward	NOUN
ajlm-916	8	28	of	of	ADP
ajlm-916	8	29	a	a	DET
ajlm-916	8	30	large	large	ADJ
ajlm-916	8	31	south	south	ADJ
ajlm-916	8	32	african	african	ADJ
ajlm-916	8	33	tertiary	tertiary	ADJ
ajlm-916	8	34	hospital	hospital	NOUN
ajlm-916	8	35	.	.	PUNCT
ajlm-916	9	1	the	the	DET
ajlm-916	9	2	rash	rash	NOUN
ajlm-916	9	3	became	become	VERB
ajlm-916	9	4	vesicular	vesicular	ADJ
ajlm-916	9	5	in	in	ADP
ajlm-916	9	6	three	three	NUM
ajlm-916	9	7	cases	case	NOUN
ajlm-916	9	8	,	,	PUNCT
ajlm-916	9	9	involving	involve	VERB
ajlm-916	9	10	the	the	DET
ajlm-916	9	11	limbs	limb	NOUN
ajlm-916	9	12	and	and	CCONJ
ajlm-916	9	13	face	face	NOUN
ajlm-916	9	14	.	.	PUNCT
ajlm-916	10	1	varicella	varicella	NOUN
ajlm-916	10	2	was	be	AUX
ajlm-916	10	3	suspected	suspect	VERB
ajlm-916	10	4	.	.	PUNCT
ajlm-916	11	1	management	management	NOUN
ajlm-916	11	2	and	and	CCONJ
ajlm-916	11	3	outcome	outcome	NOUN
ajlm-916	11	4	:	:	PUNCT
ajlm-916	11	5	medical	medical	ADJ
ajlm-916	11	6	records	record	NOUN
ajlm-916	11	7	of	of	ADP
ajlm-916	11	8	suspected	suspect	VERB
ajlm-916	11	9	cases	case	NOUN
ajlm-916	11	10	were	be	AUX
ajlm-916	11	11	reviewed	review	VERB
ajlm-916	11	12	.	.	PUNCT
ajlm-916	12	1	blood	blood	NOUN
ajlm-916	12	2	,	,	PUNCT
ajlm-916	12	3	vesicular	vesicular	ADJ
ajlm-916	12	4	fluid	fluid	NOUN
ajlm-916	12	5	and	and	CCONJ
ajlm-916	12	6	scab	scab	NOUN
ajlm-916	12	7	samples	sample	NOUN
ajlm-916	12	8	were	be	AUX
ajlm-916	12	9	collected	collect	VERB
ajlm-916	12	10	.	.	PUNCT
ajlm-916	13	1	electron	electron	NOUN
ajlm-916	13	2	microscopy	microscopy	NOUN
ajlm-916	13	3	of	of	ADP
ajlm-916	13	4	vesicular	vesicular	ADJ
ajlm-916	13	5	fluid	fluid	NOUN
ajlm-916	13	6	revealed	reveal	VERB
ajlm-916	13	7	herpes	herpe	NOUN
ajlm-916	13	8	virus	virus	NOUN
ajlm-916	13	9	particles	particle	NOUN
ajlm-916	13	10	.	.	PUNCT
ajlm-916	14	1	laboratory	laboratory	NOUN
ajlm-916	14	2	testing	testing	NOUN
ajlm-916	14	3	confirmed	confirm	VERB
ajlm-916	14	4	herpes	herpe	NOUN
ajlm-916	14	5	simplex	simplex	NOUN
ajlm-916	14	6	virus	virus	NOUN
ajlm-916	14	7	type	type	NOUN
ajlm-916	14	8	1	1	NUM
ajlm-916	14	9	.	.	PUNCT
ajlm-916	15	1	conclusion	conclusion	NOUN
ajlm-916	15	2	:	:	PUNCT
ajlm-916	15	3	herpes	herpe	NOUN
ajlm-916	15	4	simplex	simplex	NOUN
ajlm-916	15	5	virus	virus	NOUN
ajlm-916	15	6	type	type	NOUN
ajlm-916	15	7	1	1	NUM
ajlm-916	15	8	infection	infection	NOUN
ajlm-916	15	9	can	can	AUX
ajlm-916	15	10	present	present	VERB
ajlm-916	15	11	atypically	atypically	ADV
ajlm-916	15	12	in	in	ADP
ajlm-916	15	13	burns	burn	NOUN
ajlm-916	15	14	patients	patient	NOUN
ajlm-916	15	15	.	.	PUNCT
ajlm-916	16	1	keywords	keyword	NOUN
ajlm-916	16	2	:	:	PUNCT
ajlm-916	16	3	herpes	herpe	NOUN
ajlm-916	16	4	simplex	simplex	NOUN
ajlm-916	16	5	virus	virus	NOUN
ajlm-916	16	6	type	type	NOUN
ajlm-916	16	7	1	1	NUM
ajlm-916	16	8	;	;	PUNCT
ajlm-916	16	9	burns	burn	NOUN
ajlm-916	16	10	;	;	PUNCT
ajlm-916	16	11	paediatrics	paediatric	NOUN
ajlm-916	16	12	;	;	PUNCT
ajlm-916	16	13	south	south	PROPN
ajlm-916	16	14	africa	africa	PROPN
ajlm-916	16	15	.	.	PUNCT
ajlm-916	17	1	introduction	introduction	NOUN
ajlm-916	17	2	prevention	prevention	NOUN
ajlm-916	17	3	of	of	ADP
ajlm-916	17	4	infection	infection	NOUN
ajlm-916	17	5	is	be	AUX
ajlm-916	17	6	an	an	DET
ajlm-916	17	7	important	important	ADJ
ajlm-916	17	8	part	part	NOUN
ajlm-916	17	9	of	of	ADP
ajlm-916	17	10	managing	manage	VERB
ajlm-916	17	11	burns	burn	NOUN
ajlm-916	17	12	patients	patient	NOUN
ajlm-916	17	13	.	.	PUNCT
ajlm-916	18	1	prophylactic	prophylactic	ADJ
ajlm-916	18	2	administration	administration	NOUN
ajlm-916	18	3	of	of	ADP
ajlm-916	18	4	antibiotics	antibiotic	NOUN
ajlm-916	18	5	or	or	CCONJ
ajlm-916	18	6	antivirals	antiviral	NOUN
ajlm-916	18	7	is	be	AUX
ajlm-916	18	8	not	not	PART
ajlm-916	18	9	routine	routine	ADJ
ajlm-916	18	10	,	,	PUNCT
ajlm-916	18	11	with	with	ADP
ajlm-916	18	12	treatment	treatment	NOUN
ajlm-916	18	13	warranted	warrant	VERB
ajlm-916	18	14	only	only	ADV
ajlm-916	18	15	in	in	ADP
ajlm-916	18	16	patients	patient	NOUN
ajlm-916	18	17	in	in	ADP
ajlm-916	18	18	whom	whom	PRON
ajlm-916	18	19	infection	infection	NOUN
ajlm-916	18	20	is	be	AUX
ajlm-916	18	21	highly	highly	ADV
ajlm-916	18	22	suspected	suspect	VERB
ajlm-916	18	23	or	or	CCONJ
ajlm-916	18	24	proven	prove	VERB
ajlm-916	18	25	by	by	ADP
ajlm-916	18	26	laboratory	laboratory	NOUN
ajlm-916	18	27	testing.1,2,3,4	testing.1,2,3,4	ADJ
ajlm-916	18	28	differences	difference	NOUN
ajlm-916	18	29	in	in	ADP
ajlm-916	18	30	the	the	DET
ajlm-916	18	31	clinical	clinical	ADJ
ajlm-916	18	32	presentation	presentation	NOUN
ajlm-916	18	33	of	of	ADP
ajlm-916	18	34	skin	skin	NOUN
ajlm-916	18	35	infections	infection	NOUN
ajlm-916	18	36	in	in	ADP
ajlm-916	18	37	burns	burn	NOUN
ajlm-916	18	38	patients	patient	NOUN
ajlm-916	18	39	are	be	AUX
ajlm-916	18	40	not	not	PART
ajlm-916	18	41	always	always	ADV
ajlm-916	18	42	apparent	apparent	ADJ
ajlm-916	18	43	;	;	PUNCT
ajlm-916	18	44	however	however	ADV
ajlm-916	18	45	,	,	PUNCT
ajlm-916	18	46	infectious	infectious	ADJ
ajlm-916	18	47	and	and	CCONJ
ajlm-916	18	48	non	non	ADJ
ajlm-916	18	49	-	-	ADJ
ajlm-916	18	50	infectious	infectious	ADJ
ajlm-916	18	51	causes	cause	NOUN
ajlm-916	18	52	must	must	AUX
ajlm-916	18	53	be	be	AUX
ajlm-916	18	54	included	include	VERB
ajlm-916	18	55	in	in	ADP
ajlm-916	18	56	the	the	DET
ajlm-916	18	57	differential	differential	NOUN
ajlm-916	18	58	diagnosis.1,5	diagnosis.1,5	PROPN
ajlm-916	18	59	viral	viral	ADJ
ajlm-916	18	60	infections	infection	NOUN
ajlm-916	18	61	by	by	ADP
ajlm-916	18	62	members	member	NOUN
ajlm-916	18	63	of	of	ADP
ajlm-916	18	64	the	the	DET
ajlm-916	18	65	herpesviridae	herpesviridae	NOUN
ajlm-916	18	66	family	family	NOUN
ajlm-916	18	67	,	,	PUNCT
ajlm-916	18	68	including	include	VERB
ajlm-916	18	69	herpes	herpe	NOUN
ajlm-916	18	70	simplex	simplex	NOUN
ajlm-916	18	71	virus	virus	NOUN
ajlm-916	18	72	type	type	NOUN
ajlm-916	18	73	1	1	NUM
ajlm-916	18	74	(	(	PUNCT
ajlm-916	18	75	hsv1	hsv1	PROPN
ajlm-916	18	76	)	)	PUNCT
ajlm-916	18	77	,	,	PUNCT
ajlm-916	18	78	cytomegalovirus	cytomegalovirus	NOUN
ajlm-916	18	79	and	and	CCONJ
ajlm-916	18	80	varicella	varicella	NOUN
ajlm-916	18	81	-	-	PUNCT
ajlm-916	18	82	zoster	zoster	NOUN
ajlm-916	18	83	virus	virus	NOUN
ajlm-916	18	84	,	,	PUNCT
ajlm-916	18	85	have	have	AUX
ajlm-916	18	86	been	be	AUX
ajlm-916	18	87	found	find	VERB
ajlm-916	18	88	to	to	PART
ajlm-916	18	89	occur	occur	VERB
ajlm-916	18	90	commonly	commonly	ADV
ajlm-916	18	91	in	in	ADP
ajlm-916	18	92	severely	severely	ADV
ajlm-916	18	93	burnt	burn	VERB
ajlm-916	18	94	patients.4,5,6	patients.4,5,6	ADP
ajlm-916	18	95	these	these	DET
ajlm-916	18	96	infections	infection	NOUN
ajlm-916	18	97	can	can	AUX
ajlm-916	18	98	either	either	CCONJ
ajlm-916	18	99	be	be	AUX
ajlm-916	18	100	primary	primary	ADJ
ajlm-916	18	101	or	or	CCONJ
ajlm-916	18	102	due	due	ADJ
ajlm-916	18	103	to	to	ADP
ajlm-916	18	104	reactivation	reactivation	NOUN
ajlm-916	18	105	of	of	ADP
ajlm-916	18	106	a	a	DET
ajlm-916	18	107	latent	latent	NOUN
ajlm-916	18	108	virus	virus	NOUN
ajlm-916	18	109	.	.	PUNCT
ajlm-916	19	1	over	over	ADP
ajlm-916	19	2	3700	3700	NUM
ajlm-916	19	3	million	million	NUM
ajlm-916	19	4	people	people	NOUN
ajlm-916	19	5	between	between	ADP
ajlm-916	19	6	0	0	NUM
ajlm-916	19	7	and	and	CCONJ
ajlm-916	19	8	49	49	NUM
ajlm-916	19	9	years	year	NOUN
ajlm-916	19	10	have	have	AUX
ajlm-916	19	11	been	be	AUX
ajlm-916	19	12	estimated	estimate	VERB
ajlm-916	19	13	to	to	PART
ajlm-916	19	14	be	be	AUX
ajlm-916	19	15	latently	latently	ADV
ajlm-916	19	16	infected	infect	VERB
ajlm-916	19	17	with	with	ADP
ajlm-916	19	18	hsv1	hsv1	PROPN
ajlm-916	19	19	,	,	PUNCT
ajlm-916	19	20	with	with	ADP
ajlm-916	19	21	africa	africa	PROPN
ajlm-916	19	22	being	be	AUX
ajlm-916	19	23	one	one	NUM
ajlm-916	19	24	of	of	ADP
ajlm-916	19	25	the	the	DET
ajlm-916	19	26	most	most	ADV
ajlm-916	19	27	affected	affected	ADJ
ajlm-916	19	28	regions	region	NOUN
ajlm-916	19	29	globally.7	globally.7	NOUN
ajlm-916	19	30	as	as	ADP
ajlm-916	19	31	such	such	ADJ
ajlm-916	19	32	,	,	PUNCT
ajlm-916	19	33	of	of	ADP
ajlm-916	19	34	all	all	DET
ajlm-916	19	35	the	the	DET
ajlm-916	19	36	herpesviruses	herpesviruse	NOUN
ajlm-916	19	37	,	,	PUNCT
ajlm-916	19	38	hsv1	hsv1	PROPN
ajlm-916	19	39	is	be	AUX
ajlm-916	19	40	the	the	DET
ajlm-916	19	41	most	most	ADV
ajlm-916	19	42	frequently	frequently	ADV
ajlm-916	19	43	reported	report	VERB
ajlm-916	19	44	virus	virus	NOUN
ajlm-916	19	45	that	that	PRON
ajlm-916	19	46	complicates	complicate	VERB
ajlm-916	19	47	burns	burn	NOUN
ajlm-916	19	48	,	,	PUNCT
ajlm-916	19	49	whereas	whereas	SCONJ
ajlm-916	19	50	varicella	varicella	NOUN
ajlm-916	19	51	-	-	PUNCT
ajlm-916	19	52	zoster	zoster	NOUN
ajlm-916	19	53	virus	virus	NOUN
ajlm-916	19	54	infections	infection	NOUN
ajlm-916	19	55	occur	occur	VERB
ajlm-916	19	56	rarely.4	rarely.4	PROPN
ajlm-916	19	57	herpes	herpe	NOUN
ajlm-916	19	58	simplex	simplex	NOUN
ajlm-916	19	59	virus	virus	NOUN
ajlm-916	19	60	type	type	NOUN
ajlm-916	19	61	1	1	NUM
ajlm-916	19	62	infections	infection	NOUN
ajlm-916	19	63	present	present	ADJ
ajlm-916	19	64	as	as	ADP
ajlm-916	19	65	a	a	DET
ajlm-916	19	66	febrile	febrile	NOUN
ajlm-916	19	67	illness	illness	NOUN
ajlm-916	19	68	1	1	NUM
ajlm-916	19	69	to	to	PART
ajlm-916	19	70	3	3	NUM
ajlm-916	19	71	weeks	week	NOUN
ajlm-916	19	72	following	follow	VERB
ajlm-916	19	73	extensive	extensive	ADJ
ajlm-916	19	74	,	,	PUNCT
ajlm-916	19	75	full	full	ADJ
ajlm-916	19	76	-	-	PUNCT
ajlm-916	19	77	thickness	thickness	NOUN
ajlm-916	19	78	burns	burn	NOUN
ajlm-916	19	79	injuries.5,6	injuries.5,6	NOUN
ajlm-916	19	80	the	the	DET
ajlm-916	19	81	infection	infection	NOUN
ajlm-916	19	82	frequently	frequently	ADV
ajlm-916	19	83	occurs	occur	VERB
ajlm-916	19	84	in	in	ADP
ajlm-916	19	85	patients	patient	NOUN
ajlm-916	19	86	with	with	ADP
ajlm-916	19	87	burns	burn	NOUN
ajlm-916	19	88	to	to	ADP
ajlm-916	19	89	the	the	DET
ajlm-916	19	90	head	head	NOUN
ajlm-916	19	91	or	or	CCONJ
ajlm-916	19	92	neck	neck	NOUN
ajlm-916	19	93	.	.	PUNCT
ajlm-916	20	1	when	when	SCONJ
ajlm-916	20	2	associated	associate	VERB
ajlm-916	20	3	with	with	ADP
ajlm-916	20	4	burn	burn	NOUN
ajlm-916	20	5	wounds	wound	NOUN
ajlm-916	20	6	,	,	PUNCT
ajlm-916	20	7	the	the	DET
ajlm-916	20	8	lesions	lesion	NOUN
ajlm-916	20	9	typically	typically	ADV
ajlm-916	20	10	begin	begin	VERB
ajlm-916	20	11	as	as	ADP
ajlm-916	20	12	clustered	clustered	ADJ
ajlm-916	20	13	vesicles	vesicle	NOUN
ajlm-916	20	14	or	or	CCONJ
ajlm-916	20	15	vesicular	vesicular	ADJ
ajlm-916	20	16	pustules	pustule	NOUN
ajlm-916	20	17	within	within	ADP
ajlm-916	20	18	or	or	CCONJ
ajlm-916	20	19	around	around	ADP
ajlm-916	20	20	the	the	DET
ajlm-916	20	21	wound	wound	NOUN
ajlm-916	20	22	margins	margin	NOUN
ajlm-916	20	23	,	,	PUNCT
ajlm-916	20	24	with	with	ADP
ajlm-916	20	25	subsequent	subsequent	ADJ
ajlm-916	20	26	impaired	impaired	ADJ
ajlm-916	20	27	wound	wound	NOUN
ajlm-916	20	28	healing.5,6	healing.5,6	NOUN
ajlm-916	20	29	herpes	herpe	NOUN
ajlm-916	20	30	simplex	simplex	NOUN
ajlm-916	20	31	virus	virus	NOUN
ajlm-916	20	32	type	type	NOUN
ajlm-916	20	33	1	1	NUM
ajlm-916	20	34	lesions	lesion	NOUN
ajlm-916	20	35	can	can	AUX
ajlm-916	20	36	resemble	resemble	VERB
ajlm-916	20	37	those	those	PRON
ajlm-916	20	38	of	of	ADP
ajlm-916	20	39	pox	pox	NOUN
ajlm-916	20	40	viruses	virus	NOUN
ajlm-916	20	41	,	,	PUNCT
ajlm-916	20	42	with	with	ADP
ajlm-916	20	43	the	the	DET
ajlm-916	20	44	latter	latter	ADJ
ajlm-916	20	45	also	also	ADV
ajlm-916	20	46	having	having	AUX
ajlm-916	20	47	been	be	AUX
ajlm-916	20	48	identified	identify	VERB
ajlm-916	20	49	in	in	ADP
ajlm-916	20	50	burns	burn	NOUN
ajlm-916	20	51	patients.8,9	patients.8,9	PROPN
ajlm-916	20	52	cytomegalovirus	cytomegalovirus	NOUN
ajlm-916	20	53	infections	infection	NOUN
ajlm-916	20	54	have	have	AUX
ajlm-916	20	55	not	not	PART
ajlm-916	20	56	been	be	AUX
ajlm-916	20	57	shown	show	VERB
ajlm-916	20	58	to	to	PART
ajlm-916	20	59	cause	cause	VERB
ajlm-916	20	60	severe	severe	ADJ
ajlm-916	20	61	complications	complication	NOUN
ajlm-916	20	62	or	or	CCONJ
ajlm-916	20	63	increase	increase	VERB
ajlm-916	20	64	mortality	mortality	NOUN
ajlm-916	20	65	in	in	ADP
ajlm-916	20	66	burns	burn	NOUN
ajlm-916	20	67	patients.6	patients.6	NOUN
ajlm-916	20	68	however	however	ADV
ajlm-916	20	69	,	,	PUNCT
ajlm-916	20	70	the	the	DET
ajlm-916	20	71	presence	presence	NOUN
ajlm-916	20	72	of	of	ADP
ajlm-916	20	73	both	both	CCONJ
ajlm-916	20	74	primary	primary	ADJ
ajlm-916	20	75	and	and	CCONJ
ajlm-916	20	76	reactivation	reactivation	NOUN
ajlm-916	20	77	cytomegalovirus	cytomegalovirus	NOUN
ajlm-916	20	78	infections	infection	NOUN
ajlm-916	20	79	in	in	ADP
ajlm-916	20	80	severely	severely	ADV
ajlm-916	20	81	burned	burn	VERB
ajlm-916	20	82	children	child	NOUN
ajlm-916	20	83	has	have	AUX
ajlm-916	20	84	been	be	AUX
ajlm-916	20	85	recorded	record	VERB
ajlm-916	20	86	previously.6	previously.6	PROPN
ajlm-916	20	87	underlying	underlying	ADJ
ajlm-916	20	88	herpes	herpe	NOUN
ajlm-916	20	89	viral	viral	ADJ
ajlm-916	20	90	infections	infection	NOUN
ajlm-916	20	91	can	can	AUX
ajlm-916	20	92	promote	promote	VERB
ajlm-916	20	93	bacterial	bacterial	ADJ
ajlm-916	20	94	infections	infection	NOUN
ajlm-916	20	95	,	,	PUNCT
ajlm-916	20	96	resulting	result	VERB
ajlm-916	20	97	in	in	ADP
ajlm-916	20	98	prolonged	prolonged	ADJ
ajlm-916	20	99	hospitalisation	hospitalisation	NOUN
ajlm-916	20	100	,	,	PUNCT
ajlm-916	20	101	need	need	VERB
ajlm-916	20	102	for	for	ADP
ajlm-916	20	103	mechanical	mechanical	ADJ
ajlm-916	20	104	ventilation	ventilation	NOUN
ajlm-916	20	105	,	,	PUNCT
ajlm-916	20	106	delayed	delay	VERB
ajlm-916	20	107	recovery	recovery	NOUN
ajlm-916	20	108	and	and	CCONJ
ajlm-916	20	109	higher	high	ADJ
ajlm-916	20	110	mortality	mortality	NOUN
ajlm-916	20	111	rates.1,4,10,11	rates.1,4,10,11	NOUN
ajlm-916	20	112	herpes	herpe	VERB
ajlm-916	20	113	viral	viral	ADJ
ajlm-916	20	114	infections	infection	NOUN
ajlm-916	20	115	in	in	ADP
ajlm-916	20	116	burns	burn	NOUN
ajlm-916	20	117	patients	patient	NOUN
ajlm-916	20	118	have	have	AUX
ajlm-916	20	119	not	not	PART
ajlm-916	20	120	been	be	AUX
ajlm-916	20	121	described	describe	VERB
ajlm-916	20	122	in	in	ADP
ajlm-916	20	123	the	the	DET
ajlm-916	20	124	south	south	ADJ
ajlm-916	20	125	african	african	ADJ
ajlm-916	20	126	setting	setting	NOUN
ajlm-916	20	127	.	.	PUNCT
ajlm-916	21	1	however	however	ADV
ajlm-916	21	2	,	,	PUNCT
ajlm-916	21	3	due	due	ADP
ajlm-916	21	4	to	to	ADP
ajlm-916	21	5	the	the	DET
ajlm-916	21	6	contagious	contagious	ADJ
ajlm-916	21	7	nature	nature	NOUN
ajlm-916	21	8	of	of	ADP
ajlm-916	21	9	these	these	DET
ajlm-916	21	10	infections	infection	NOUN
ajlm-916	21	11	,	,	PUNCT
ajlm-916	21	12	there	there	PRON
ajlm-916	21	13	are	be	VERB
ajlm-916	21	14	implications	implication	NOUN
ajlm-916	21	15	for	for	ADP
ajlm-916	21	16	infection	infection	NOUN
ajlm-916	21	17	prevention	prevention	NOUN
ajlm-916	21	18	and	and	CCONJ
ajlm-916	21	19	control	control	NOUN
ajlm-916	21	20	practices	practice	NOUN
ajlm-916	21	21	,	,	PUNCT
ajlm-916	21	22	particularly	particularly	ADV
ajlm-916	21	23	in	in	ADP
ajlm-916	21	24	the	the	DET
ajlm-916	21	25	sub	sub	NOUN
ajlm-916	21	26	-	-	NOUN
ajlm-916	21	27	population	population	NOUN
ajlm-916	21	28	of	of	ADP
ajlm-916	21	29	immunosuppressed	immunosuppressed	ADJ
ajlm-916	21	30	burns	burn	NOUN
ajlm-916	21	31	patients	patient	NOUN
ajlm-916	21	32	.	.	PUNCT
ajlm-916	22	1	in	in	ADP
ajlm-916	22	2	addition	addition	NOUN
ajlm-916	22	3	,	,	PUNCT
ajlm-916	22	4	possible	possible	ADJ
ajlm-916	22	5	complications	complication	NOUN
ajlm-916	22	6	such	such	ADJ
ajlm-916	22	7	as	as	ADP
ajlm-916	22	8	hsv1	hsv1	PROPN
ajlm-916	22	9	-	-	PUNCT
ajlm-916	22	10	associated	associate	VERB
ajlm-916	22	11	encephalitis	encephalitis	NOUN
ajlm-916	22	12	make	make	VERB
ajlm-916	22	13	knowledge	knowledge	NOUN
ajlm-916	22	14	on	on	ADP
ajlm-916	22	15	the	the	DET
ajlm-916	22	16	management	management	NOUN
ajlm-916	22	17	of	of	ADP
ajlm-916	22	18	these	these	DET
ajlm-916	22	19	infections	infection	NOUN
ajlm-916	22	20	important	important	ADJ
ajlm-916	22	21	.	.	PUNCT
ajlm-916	23	1	ethical	ethical	ADJ
ajlm-916	23	2	considerations	consideration	NOUN
ajlm-916	23	3	due	due	ADP
ajlm-916	23	4	to	to	ADP
ajlm-916	23	5	the	the	DET
ajlm-916	23	6	initial	initial	ADJ
ajlm-916	23	7	presentation	presentation	NOUN
ajlm-916	23	8	as	as	ADP
ajlm-916	23	9	a	a	DET
ajlm-916	23	10	febrile	febrile	NOUN
ajlm-916	23	11	maculopapular	maculopapular	ADJ
ajlm-916	23	12	rash	rash	NOUN
ajlm-916	23	13	illness	illness	NOUN
ajlm-916	23	14	,	,	PUNCT
ajlm-916	23	15	the	the	DET
ajlm-916	23	16	cluster	cluster	NOUN
ajlm-916	23	17	was	be	AUX
ajlm-916	23	18	initially	initially	ADV
ajlm-916	23	19	investigated	investigate	VERB
ajlm-916	23	20	as	as	ADP
ajlm-916	23	21	a	a	DET
ajlm-916	23	22	possible	possible	ADJ
ajlm-916	23	23	measles	measle	NOUN
ajlm-916	23	24	outbreak	outbreak	NOUN
ajlm-916	23	25	.	.	PUNCT
ajlm-916	24	1	all	all	DET
ajlm-916	24	2	outbreak	outbreak	NOUN
ajlm-916	24	3	investigations	investigation	NOUN
ajlm-916	24	4	,	,	PUNCT
ajlm-916	24	5	which	which	PRON
ajlm-916	24	6	would	would	AUX
ajlm-916	24	7	include	include	VERB
ajlm-916	24	8	history	history	NOUN
ajlm-916	24	9	taking	taking	NOUN
ajlm-916	24	10	(	(	PUNCT
ajlm-916	24	11	in	in	ADP
ajlm-916	24	12	this	this	DET
ajlm-916	24	13	case	case	NOUN
ajlm-916	24	14	,	,	PUNCT
ajlm-916	24	15	from	from	ADP
ajlm-916	24	16	the	the	DET
ajlm-916	24	17	parents	parent	NOUN
ajlm-916	24	18	in	in	ADP
ajlm-916	24	19	light	light	NOUN
ajlm-916	24	20	of	of	ADP
ajlm-916	24	21	the	the	DET
ajlm-916	24	22	patients	patient	NOUN
ajlm-916	24	23	’	’	PART
ajlm-916	24	24	ages	age	NOUN
ajlm-916	24	25	)	)	PUNCT
ajlm-916	24	26	,	,	PUNCT
ajlm-916	24	27	patient	patient	ADJ
ajlm-916	24	28	examination	examination	NOUN
ajlm-916	24	29	as	as	ADV
ajlm-916	24	30	well	well	ADV
ajlm-916	24	31	as	as	ADP
ajlm-916	24	32	sample	sample	NOUN
ajlm-916	24	33	collection	collection	NOUN
ajlm-916	24	34	,	,	PUNCT
ajlm-916	24	35	that	that	PRON
ajlm-916	24	36	are	be	AUX
ajlm-916	24	37	conducted	conduct	VERB
ajlm-916	24	38	by	by	ADP
ajlm-916	24	39	the	the	DET
ajlm-916	24	40	national	national	PROPN
ajlm-916	24	41	institute	institute	PROPN
ajlm-916	24	42	for	for	ADP
ajlm-916	24	43	communicable	communicable	NOUN
ajlm-916	24	44	diseases	disease	NOUN
ajlm-916	24	45	have	have	VERB
ajlm-916	24	46	ethics	ethic	NOUN
ajlm-916	24	47	clearance	clearance	NOUN
ajlm-916	24	48	from	from	ADP
ajlm-916	24	49	the	the	DET
ajlm-916	24	50	human	human	ADJ
ajlm-916	24	51	research	research	PROPN
ajlm-916	24	52	ethics	ethic	NOUN
ajlm-916	24	53	committee	committee	PROPN
ajlm-916	24	54	of	of	ADP
ajlm-916	24	55	the	the	DET
ajlm-916	24	56	university	university	NOUN
ajlm-916	24	57	of	of	ADP
ajlm-916	24	58	the	the	DET
ajlm-916	24	59	witwatersrand	witwatersrand	NOUN
ajlm-916	24	60	,	,	PUNCT
ajlm-916	24	61	south	south	PROPN
ajlm-916	24	62	africa	africa	PROPN
ajlm-916	24	63	(	(	PUNCT
ajlm-916	24	64	m160667	m160667	PROPN
ajlm-916	24	65	,	,	PUNCT
ajlm-916	24	66	2016–2020	2016–2020	NUM
ajlm-916	24	67	)	)	PUNCT
ajlm-916	24	68	.	.	PUNCT
ajlm-916	25	1	in	in	ADP
ajlm-916	25	2	terms	term	NOUN
ajlm-916	25	3	of	of	ADP
ajlm-916	25	4	this	this	DET
ajlm-916	25	5	ethics	ethic	NOUN
ajlm-916	25	6	clearance	clearance	NOUN
ajlm-916	25	7	,	,	PUNCT
ajlm-916	25	8	patient	patient	ADJ
ajlm-916	25	9	consent	consent	NOUN
ajlm-916	25	10	is	be	AUX
ajlm-916	25	11	not	not	PART
ajlm-916	25	12	required	require	VERB
ajlm-916	25	13	and	and	CCONJ
ajlm-916	25	14	any	any	DET
ajlm-916	25	15	patient	patient	ADJ
ajlm-916	25	16	specimen	speciman	NOUN
ajlm-916	25	17	collected	collect	VERB
ajlm-916	25	18	is	be	AUX
ajlm-916	25	19	anonymised	anonymise	VERB
ajlm-916	25	20	case	case	NOUN
ajlm-916	25	21	presentation	presentation	NOUN
ajlm-916	25	22	during	during	ADP
ajlm-916	25	23	july	july	PROPN
ajlm-916	25	24	2017	2017	NUM
ajlm-916	25	25	,	,	PUNCT
ajlm-916	25	26	seven	seven	NUM
ajlm-916	25	27	paediatric	paediatric	ADJ
ajlm-916	25	28	burns	burn	NOUN
ajlm-916	25	29	patients	patient	NOUN
ajlm-916	25	30	between	between	ADP
ajlm-916	25	31	the	the	DET
ajlm-916	25	32	ages	age	NOUN
ajlm-916	25	33	of	of	ADP
ajlm-916	25	34	10	10	NUM
ajlm-916	25	35	months	month	NOUN
ajlm-916	25	36	and	and	CCONJ
ajlm-916	25	37	5	5	NUM
ajlm-916	25	38	years	year	NOUN
ajlm-916	25	39	presented	present	VERB
ajlm-916	25	40	with	with	ADP
ajlm-916	25	41	a	a	DET
ajlm-916	25	42	maculopapular	maculopapular	ADJ
ajlm-916	25	43	rash	rash	NOUN
ajlm-916	25	44	at	at	ADP
ajlm-916	25	45	a	a	DET
ajlm-916	25	46	tertiary	tertiary	ADJ
ajlm-916	25	47	hospital	hospital	NOUN
ajlm-916	25	48	in	in	ADP
ajlm-916	25	49	gauteng	gauteng	PROPN
ajlm-916	25	50	,	,	PUNCT
ajlm-916	25	51	south	south	PROPN
ajlm-916	25	52	africa	africa	PROPN
ajlm-916	25	53	.	.	PUNCT
ajlm-916	26	1	four	four	NUM
ajlm-916	26	2	of	of	ADP
ajlm-916	26	3	these	these	DET
ajlm-916	26	4	patients	patient	NOUN
ajlm-916	26	5	were	be	AUX
ajlm-916	26	6	female	female	ADJ
ajlm-916	26	7	.	.	PUNCT
ajlm-916	27	1	the	the	DET
ajlm-916	27	2	rash	rash	NOUN
ajlm-916	27	3	was	be	AUX
ajlm-916	27	4	associated	associate	VERB
ajlm-916	27	5	with	with	ADP
ajlm-916	27	6	both	both	DET
ajlm-916	27	7	fever	fever	NOUN
ajlm-916	27	8	and	and	CCONJ
ajlm-916	27	9	coryza	coryza	NOUN
ajlm-916	27	10	in	in	ADP
ajlm-916	27	11	four	four	NUM
ajlm-916	27	12	of	of	ADP
ajlm-916	27	13	the	the	DET
ajlm-916	27	14	cases	case	NOUN
ajlm-916	27	15	.	.	PUNCT
ajlm-916	28	1	the	the	DET
ajlm-916	28	2	characteristics	characteristic	NOUN
ajlm-916	28	3	of	of	ADP
ajlm-916	28	4	the	the	DET
ajlm-916	28	5	cases	case	NOUN
ajlm-916	28	6	involved	involve	VERB
ajlm-916	28	7	in	in	ADP
ajlm-916	28	8	this	this	DET
ajlm-916	28	9	cluster	cluster	NOUN
ajlm-916	28	10	are	be	AUX
ajlm-916	28	11	shown	show	VERB
ajlm-916	28	12	in	in	ADP
ajlm-916	28	13	table	table	NOUN
ajlm-916	28	14	1	1	NUM
ajlm-916	28	15	.	.	PUNCT
ajlm-916	29	1	the	the	DET
ajlm-916	29	2	cluster	cluster	NOUN
ajlm-916	29	3	was	be	AUX
ajlm-916	29	4	reported	report	VERB
ajlm-916	29	5	to	to	ADP
ajlm-916	29	6	the	the	DET
ajlm-916	29	7	national	national	PROPN
ajlm-916	29	8	institute	institute	PROPN
ajlm-916	29	9	for	for	ADP
ajlm-916	29	10	communicable	communicable	NOUN
ajlm-916	29	11	diseases	disease	NOUN
ajlm-916	29	12	.	.	PUNCT
ajlm-916	30	1	due	due	ADP
ajlm-916	30	2	to	to	ADP
ajlm-916	30	3	a	a	DET
ajlm-916	30	4	concurrent	concurrent	ADJ
ajlm-916	30	5	measles	measle	NOUN
ajlm-916	30	6	outbreak	outbreak	VERB
ajlm-916	30	7	in	in	ADP
ajlm-916	30	8	the	the	DET
ajlm-916	30	9	province	province	NOUN
ajlm-916	30	10	,	,	PUNCT
ajlm-916	30	11	measles	measle	NOUN
ajlm-916	30	12	was	be	AUX
ajlm-916	30	13	initially	initially	ADV
ajlm-916	30	14	suspected	suspect	VERB
ajlm-916	30	15	.	.	PUNCT
ajlm-916	31	1	the	the	DET
ajlm-916	31	2	rash	rash	NOUN
ajlm-916	31	3	subsequently	subsequently	ADV
ajlm-916	31	4	evolved	evolve	VERB
ajlm-916	31	5	and	and	CCONJ
ajlm-916	31	6	became	become	VERB
ajlm-916	31	7	vesicular	vesicular	ADJ
ajlm-916	31	8	in	in	ADP
ajlm-916	31	9	two	two	NUM
ajlm-916	31	10	of	of	ADP
ajlm-916	31	11	the	the	DET
ajlm-916	31	12	cases	case	NOUN
ajlm-916	31	13	,	,	PUNCT
ajlm-916	31	14	affecting	affect	VERB
ajlm-916	31	15	the	the	DET
ajlm-916	31	16	limbs	limb	NOUN
ajlm-916	31	17	and	and	CCONJ
ajlm-916	31	18	hands	hand	NOUN
ajlm-916	31	19	in	in	ADP
ajlm-916	31	20	one	one	NUM
ajlm-916	31	21	of	of	ADP
ajlm-916	31	22	the	the	DET
ajlm-916	31	23	cases	case	NOUN
ajlm-916	31	24	(	(	PUNCT
ajlm-916	31	25	figure	figure	NOUN
ajlm-916	31	26	1	1	NUM
ajlm-916	31	27	)	)	PUNCT
ajlm-916	31	28	.	.	PUNCT
ajlm-916	32	1	contemporaneously	contemporaneously	ADV
ajlm-916	32	2	,	,	PUNCT
ajlm-916	32	3	an	an	DET
ajlm-916	32	4	eighth	eighth	ADJ
ajlm-916	32	5	patient	patient	NOUN
ajlm-916	32	6	presented	present	VERB
ajlm-916	32	7	with	with	ADP
ajlm-916	32	8	a	a	DET
ajlm-916	32	9	vesicular	vesicular	ADJ
ajlm-916	32	10	rash	rash	NOUN
ajlm-916	32	11	on	on	ADP
ajlm-916	32	12	the	the	DET
ajlm-916	32	13	trunk	trunk	NOUN
ajlm-916	32	14	and	and	CCONJ
ajlm-916	32	15	on	on	ADP
ajlm-916	32	16	both	both	CCONJ
ajlm-916	32	17	upper	upper	ADJ
ajlm-916	32	18	and	and	CCONJ
ajlm-916	32	19	lower	low	ADJ
ajlm-916	32	20	extremities	extremity	NOUN
ajlm-916	32	21	bilaterally	bilaterally	ADV
ajlm-916	32	22	.	.	PUNCT
ajlm-916	33	1	of	of	ADP
ajlm-916	33	2	note	note	NOUN
ajlm-916	33	3	is	be	AUX
ajlm-916	33	4	that	that	SCONJ
ajlm-916	33	5	this	this	DET
ajlm-916	33	6	patient	patient	NOUN
ajlm-916	33	7	did	do	AUX
ajlm-916	33	8	not	not	PART
ajlm-916	33	9	initially	initially	ADV
ajlm-916	33	10	present	present	VERB
ajlm-916	33	11	with	with	ADP
ajlm-916	33	12	a	a	DET
ajlm-916	33	13	maculopapular	maculopapular	ADJ
ajlm-916	33	14	rash	rash	NOUN
ajlm-916	33	15	.	.	PUNCT
ajlm-916	34	1	varicella	varicella	NOUN
ajlm-916	34	2	-	-	NOUN
ajlm-916	34	3	zoster	zoster	NOUN
ajlm-916	34	4	became	become	VERB
ajlm-916	34	5	a	a	DET
ajlm-916	34	6	differential	differential	ADJ
ajlm-916	34	7	diagnosis	diagnosis	NOUN
ajlm-916	34	8	.	.	PUNCT
ajlm-916	35	1	as	as	SCONJ
ajlm-916	35	2	children	child	NOUN
ajlm-916	35	3	are	be	AUX
ajlm-916	35	4	not	not	PART
ajlm-916	35	5	routinely	routinely	ADV
ajlm-916	35	6	immunised	immunise	VERB
ajlm-916	35	7	against	against	ADP
ajlm-916	35	8	varicella	varicella	NOUN
ajlm-916	35	9	in	in	ADP
ajlm-916	35	10	south	south	PROPN
ajlm-916	35	11	africa	africa	PROPN
ajlm-916	35	12	’s	’s	PART
ajlm-916	35	13	public	public	ADJ
ajlm-916	35	14	health	health	NOUN
ajlm-916	35	15	sector	sector	NOUN
ajlm-916	35	16	,	,	PUNCT
ajlm-916	35	17	the	the	DET
ajlm-916	35	18	cost	cost	NOUN
ajlm-916	35	19	,	,	PUNCT
ajlm-916	35	20	availability	availability	NOUN
ajlm-916	35	21	and	and	CCONJ
ajlm-916	35	22	resource	resource	NOUN
ajlm-916	35	23	utilisation	utilisation	NOUN
ajlm-916	35	24	of	of	ADP
ajlm-916	35	25	prophylactic	prophylactic	ADJ
ajlm-916	35	26	varicella	varicella	NOUN
ajlm-916	35	27	immunoglobulins	immunoglobulin	NOUN
ajlm-916	35	28	for	for	ADP
ajlm-916	35	29	the	the	DET
ajlm-916	35	30	cases	case	NOUN
ajlm-916	35	31	posed	pose	VERB
ajlm-916	35	32	a	a	DET
ajlm-916	35	33	number	number	NOUN
ajlm-916	35	34	of	of	ADP
ajlm-916	35	35	challenges.6	challenges.6	PROPN
ajlm-916	35	36	the	the	DET
ajlm-916	35	37	natural	natural	ADJ
ajlm-916	35	38	history	history	NOUN
ajlm-916	35	39	in	in	ADP
ajlm-916	35	40	the	the	DET
ajlm-916	35	41	cases	case	NOUN
ajlm-916	35	42	that	that	PRON
ajlm-916	35	43	developed	develop	VERB
ajlm-916	35	44	the	the	DET
ajlm-916	35	45	vesicular	vesicular	ADJ
ajlm-916	35	46	lesions	lesion	NOUN
ajlm-916	35	47	was	be	AUX
ajlm-916	35	48	also	also	ADV
ajlm-916	35	49	atypical	atypical	ADJ
ajlm-916	35	50	of	of	ADP
ajlm-916	35	51	the	the	DET
ajlm-916	35	52	varicella	varicella	NOUN
ajlm-916	35	53	-	-	PUNCT
ajlm-916	35	54	zoster	zoster	NOUN
ajlm-916	35	55	infection	infection	NOUN
ajlm-916	35	56	.	.	PUNCT
ajlm-916	36	1	there	there	PRON
ajlm-916	36	2	was	be	VERB
ajlm-916	36	3	therefore	therefore	ADV
ajlm-916	36	4	a	a	DET
ajlm-916	36	5	possibility	possibility	NOUN
ajlm-916	36	6	of	of	ADP
ajlm-916	36	7	administering	administer	VERB
ajlm-916	36	8	the	the	DET
ajlm-916	36	9	immunoglobulins	immunoglobulin	NOUN
ajlm-916	36	10	unnecessarily	unnecessarily	ADV
ajlm-916	36	11	.	.	PUNCT
ajlm-916	37	1	other	other	ADJ
ajlm-916	37	2	possible	possible	ADJ
ajlm-916	37	3	diagnoses	diagnosis	NOUN
ajlm-916	37	4	that	that	PRON
ajlm-916	37	5	were	be	AUX
ajlm-916	37	6	considered	consider	VERB
ajlm-916	37	7	included	include	VERB
ajlm-916	37	8	enterovirus	enterovirus	NOUN
ajlm-916	37	9	and	and	CCONJ
ajlm-916	37	10	pox	pox	NOUN
ajlm-916	37	11	infections	infection	NOUN
ajlm-916	37	12	.	.	PUNCT
ajlm-916	38	1	an	an	DET
ajlm-916	38	2	investigation	investigation	NOUN
ajlm-916	38	3	was	be	AUX
ajlm-916	38	4	initiated	initiate	VERB
ajlm-916	38	5	by	by	ADP
ajlm-916	38	6	the	the	DET
ajlm-916	38	7	national	national	PROPN
ajlm-916	38	8	institute	institute	PROPN
ajlm-916	38	9	for	for	ADP
ajlm-916	38	10	communicable	communicable	NOUN
ajlm-916	38	11	diseases	disease	NOUN
ajlm-916	38	12	in	in	ADP
ajlm-916	38	13	order	order	NOUN
ajlm-916	38	14	to	to	PART
ajlm-916	38	15	establish	establish	VERB
ajlm-916	38	16	the	the	DET
ajlm-916	38	17	cause	cause	NOUN
ajlm-916	38	18	of	of	ADP
ajlm-916	38	19	the	the	DET
ajlm-916	38	20	illness	illness	NOUN
ajlm-916	38	21	.	.	PUNCT
ajlm-916	39	1	a	a	DET
ajlm-916	39	2	composite	composite	ADJ
ajlm-916	39	3	case	case	NOUN
ajlm-916	39	4	definition	definition	NOUN
ajlm-916	39	5	that	that	PRON
ajlm-916	39	6	was	be	AUX
ajlm-916	39	7	used	use	VERB
ajlm-916	39	8	to	to	PART
ajlm-916	39	9	identify	identify	VERB
ajlm-916	39	10	other	other	ADJ
ajlm-916	39	11	cases	case	NOUN
ajlm-916	39	12	in	in	ADP
ajlm-916	39	13	the	the	DET
ajlm-916	39	14	ward	ward	NOUN
ajlm-916	39	15	included	include	VERB
ajlm-916	39	16	any	any	DET
ajlm-916	39	17	patient	patient	NOUN
ajlm-916	39	18	who	who	PRON
ajlm-916	39	19	was	be	AUX
ajlm-916	39	20	admitted	admit	VERB
ajlm-916	39	21	to	to	ADP
ajlm-916	39	22	the	the	DET
ajlm-916	39	23	unit	unit	NOUN
ajlm-916	39	24	during	during	ADP
ajlm-916	39	25	july	july	PROPN
ajlm-916	39	26	2017	2017	NUM
ajlm-916	39	27	,	,	PUNCT
ajlm-916	39	28	presenting	present	VERB
ajlm-916	39	29	with	with	ADP
ajlm-916	39	30	a	a	DET
ajlm-916	39	31	maculopapular	maculopapular	ADJ
ajlm-916	39	32	or	or	CCONJ
ajlm-916	39	33	vesicular	vesicular	ADJ
ajlm-916	39	34	rash	rash	NOUN
ajlm-916	39	35	,	,	PUNCT
ajlm-916	39	36	with	with	ADP
ajlm-916	39	37	or	or	CCONJ
ajlm-916	39	38	without	without	ADP
ajlm-916	39	39	fever	fever	NOUN
ajlm-916	39	40	or	or	CCONJ
ajlm-916	39	41	coryza	coryza	NOUN
ajlm-916	39	42	.	.	PUNCT
ajlm-916	40	1	the	the	DET
ajlm-916	40	2	medical	medical	ADJ
ajlm-916	40	3	records	record	NOUN
ajlm-916	40	4	of	of	ADP
ajlm-916	40	5	suspected	suspect	VERB
ajlm-916	40	6	cases	case	NOUN
ajlm-916	40	7	were	be	AUX
ajlm-916	40	8	reviewed	review	VERB
ajlm-916	40	9	using	use	VERB
ajlm-916	40	10	a	a	DET
ajlm-916	40	11	pre	pre	ADJ
ajlm-916	40	12	-	-	ADJ
ajlm-916	40	13	designed	design	VERB
ajlm-916	40	14	case	case	NOUN
ajlm-916	40	15	investigation	investigation	NOUN
ajlm-916	40	16	form	form	NOUN
ajlm-916	40	17	.	.	PUNCT
ajlm-916	41	1	cases	case	NOUN
ajlm-916	41	2	were	be	AUX
ajlm-916	41	3	also	also	ADV
ajlm-916	41	4	examined	examine	VERB
ajlm-916	41	5	for	for	ADP
ajlm-916	41	6	any	any	DET
ajlm-916	41	7	residual	residual	ADJ
ajlm-916	41	8	or	or	CCONJ
ajlm-916	41	9	new	new	ADJ
ajlm-916	41	10	symptoms	symptom	NOUN
ajlm-916	41	11	.	.	PUNCT
ajlm-916	42	1	further	further	ADJ
ajlm-916	42	2	information	information	NOUN
ajlm-916	42	3	on	on	ADP
ajlm-916	42	4	the	the	DET
ajlm-916	42	5	history	history	NOUN
ajlm-916	42	6	of	of	ADP
ajlm-916	42	7	the	the	DET
ajlm-916	42	8	illness	illness	NOUN
ajlm-916	42	9	was	be	AUX
ajlm-916	42	10	also	also	ADV
ajlm-916	42	11	obtained	obtain	VERB
ajlm-916	42	12	from	from	ADP
ajlm-916	42	13	the	the	DET
ajlm-916	42	14	caregivers	caregiver	NOUN
ajlm-916	42	15	of	of	ADP
ajlm-916	42	16	some	some	PRON
ajlm-916	42	17	of	of	ADP
ajlm-916	42	18	the	the	DET
ajlm-916	42	19	cases	case	NOUN
ajlm-916	42	20	.	.	PUNCT
ajlm-916	43	1	blood	blood	NOUN
ajlm-916	43	2	samples	sample	NOUN
ajlm-916	43	3	were	be	AUX
ajlm-916	43	4	collected	collect	VERB
ajlm-916	43	5	for	for	ADP
ajlm-916	43	6	serological	serological	ADJ
ajlm-916	43	7	and	and	CCONJ
ajlm-916	43	8	molecular	molecular	ADJ
ajlm-916	43	9	testing	testing	NOUN
ajlm-916	43	10	using	use	VERB
ajlm-916	43	11	the	the	DET
ajlm-916	43	12	following	follow	VERB
ajlm-916	43	13	assays	assay	NOUN
ajlm-916	43	14	:	:	PUNCT
ajlm-916	43	15	siemens	siemens	PROPN
ajlm-916	43	16	enzygnost	enzygnost	PROPN
ajlm-916	43	17	®	®	PROPN
ajlm-916	43	18	measles	measle	NOUN
ajlm-916	43	19	igm	igm	NOUN
ajlm-916	43	20	and	and	CCONJ
ajlm-916	43	21	rubella	rubella	NOUN
ajlm-916	43	22	igm	igm	PROPN
ajlm-916	43	23	eia	eia	PROPN
ajlm-916	43	24	(	(	PUNCT
ajlm-916	43	25	siemens	siemens	PROPN
ajlm-916	43	26	,	,	PUNCT
ajlm-916	43	27	marburg	marburg	PROPN
ajlm-916	43	28	,	,	PUNCT
ajlm-916	43	29	germany	germany	PROPN
ajlm-916	43	30	)	)	PUNCT
ajlm-916	43	31	,	,	PUNCT
ajlm-916	43	32	liaison	liaison	NOUN
ajlm-916	43	33	®	®	NOUN
ajlm-916	43	34	vzv	vzv	PROPN
ajlm-916	43	35	igm	igm	PROPN
ajlm-916	43	36	clia	clia	PROPN
ajlm-916	43	37	(	(	PUNCT
ajlm-916	43	38	diasorin	diasorin	NOUN
ajlm-916	43	39	,	,	PUNCT
ajlm-916	43	40	saluggia	saluggia	PROPN
ajlm-916	43	41	,	,	PUNCT
ajlm-916	43	42	italy	italy	PROPN
ajlm-916	43	43	)	)	PUNCT
ajlm-916	43	44	,	,	PUNCT
ajlm-916	43	45	herpeselect	herpeselect	PROPN
ajlm-916	43	46	®	®	NOUN
ajlm-916	43	47	hsv-1	hsv-1	X
ajlm-916	43	48	eia	eia	NOUN
ajlm-916	43	49	(	(	PUNCT
ajlm-916	43	50	focus	focus	NOUN
ajlm-916	43	51	diagnostics	diagnostic	NOUN
ajlm-916	43	52	,	,	PUNCT
ajlm-916	43	53	cypress	cypress	PROPN
ajlm-916	43	54	,	,	PUNCT
ajlm-916	43	55	california	california	PROPN
ajlm-916	43	56	,	,	PUNCT
ajlm-916	43	57	united	united	PROPN
ajlm-916	43	58	states	states	PROPN
ajlm-916	43	59	)	)	PUNCT
ajlm-916	43	60	,	,	PUNCT
ajlm-916	43	61	genesig	genesig	NOUN
ajlm-916	43	62	®	®	NOUN
ajlm-916	43	63	herpes	herpe	NOUN
ajlm-916	43	64	simplex	simplex	NOUN
ajlm-916	43	65	virus	virus	NOUN
ajlm-916	43	66	type	type	NOUN
ajlm-916	43	67	1	1	NUM
ajlm-916	43	68	and	and	CCONJ
ajlm-916	43	69	2	2	NUM
ajlm-916	43	70	real	real	ADJ
ajlm-916	43	71	-	-	PUNCT
ajlm-916	43	72	time	time	NOUN
ajlm-916	43	73	polymerase	polymerase	NOUN
ajlm-916	43	74	chain	chain	NOUN
ajlm-916	43	75	reaction	reaction	NOUN
ajlm-916	43	76	kit	kit	NOUN
ajlm-916	43	77	(	(	PUNCT
ajlm-916	43	78	primerdesign	primerdesign	PROPN
ajlm-916	43	79	ltd	ltd	PROPN
ajlm-916	43	80	,	,	PUNCT
ajlm-916	43	81	southampton	southampton	PROPN
ajlm-916	43	82	,	,	PUNCT
ajlm-916	43	83	hampshire	hampshire	PROPN
ajlm-916	43	84	,	,	PUNCT
ajlm-916	43	85	united	united	ADJ
ajlm-916	43	86	kingdom	kingdom	PROPN
ajlm-916	43	87	)	)	PUNCT
ajlm-916	43	88	.	.	PUNCT
ajlm-916	44	1	vesicular	vesicular	ADJ
ajlm-916	44	2	fluid	fluid	NOUN
ajlm-916	44	3	and	and	CCONJ
ajlm-916	44	4	scab	scab	NOUN
ajlm-916	44	5	samples	sample	NOUN
ajlm-916	44	6	were	be	AUX
ajlm-916	44	7	collected	collect	VERB
ajlm-916	44	8	and	and	CCONJ
ajlm-916	44	9	submitted	submit	VERB
ajlm-916	44	10	to	to	ADP
ajlm-916	44	11	the	the	DET
ajlm-916	44	12	national	national	PROPN
ajlm-916	44	13	institute	institute	PROPN
ajlm-916	44	14	for	for	ADP
ajlm-916	44	15	communicable	communicable	NOUN
ajlm-916	44	16	diseases	disease	NOUN
ajlm-916	44	17	for	for	ADP
ajlm-916	44	18	transmission	transmission	NOUN
ajlm-916	44	19	electron	electron	NOUN
ajlm-916	44	20	microscopy	microscopy	NOUN
ajlm-916	44	21	using	use	VERB
ajlm-916	44	22	negative	negative	ADJ
ajlm-916	44	23	staining.9	staining.9	PROPN
ajlm-916	44	24	figure	figure	NOUN
ajlm-916	44	25	1	1	NUM
ajlm-916	44	26	:	:	PUNCT
ajlm-916	44	27	vesicular	vesicular	ADJ
ajlm-916	44	28	lesions	lesion	NOUN
ajlm-916	44	29	on	on	ADP
ajlm-916	44	30	two	two	NUM
ajlm-916	44	31	of	of	ADP
ajlm-916	44	32	the	the	DET
ajlm-916	44	33	cases	case	NOUN
ajlm-916	44	34	,	,	PUNCT
ajlm-916	44	35	gauteng	gauteng	PROPN
ajlm-916	44	36	,	,	PUNCT
ajlm-916	44	37	south	south	PROPN
ajlm-916	44	38	africa	africa	PROPN
ajlm-916	44	39	,	,	PUNCT
ajlm-916	44	40	july	july	PROPN
ajlm-916	44	41	2017	2017	NUM
ajlm-916	44	42	.	.	PUNCT
ajlm-916	45	1	(	(	PUNCT
ajlm-916	45	2	a	a	DET
ajlm-916	45	3	,	,	PUNCT
ajlm-916	45	4	b	b	NOUN
ajlm-916	45	5	)	)	PUNCT
ajlm-916	45	6	vesicular	vesicular	ADJ
ajlm-916	45	7	lesions	lesion	NOUN
ajlm-916	45	8	seen	see	VERB
ajlm-916	45	9	on	on	ADP
ajlm-916	45	10	one	one	NUM
ajlm-916	45	11	of	of	ADP
ajlm-916	45	12	the	the	DET
ajlm-916	45	13	cases	case	NOUN
ajlm-916	45	14	that	that	PRON
ajlm-916	45	15	initially	initially	ADV
ajlm-916	45	16	presented	present	VERB
ajlm-916	45	17	with	with	ADP
ajlm-916	45	18	a	a	DET
ajlm-916	45	19	maculopapular	maculopapular	ADJ
ajlm-916	45	20	rash	rash	NOUN
ajlm-916	45	21	.	.	PUNCT
ajlm-916	46	1	(	(	PUNCT
ajlm-916	46	2	c	c	X
ajlm-916	46	3	,	,	PUNCT
ajlm-916	46	4	d	d	NOUN
ajlm-916	46	5	)	)	PUNCT
ajlm-916	46	6	vesicular	vesicular	ADJ
ajlm-916	46	7	lesions	lesion	NOUN
ajlm-916	46	8	on	on	ADP
ajlm-916	46	9	the	the	DET
ajlm-916	46	10	third	third	ADJ
ajlm-916	46	11	case	case	NOUN
ajlm-916	46	12	.	.	PUNCT
ajlm-916	47	1	this	this	DET
ajlm-916	47	2	patient	patient	NOUN
ajlm-916	47	3	was	be	AUX
ajlm-916	47	4	not	not	PART
ajlm-916	47	5	part	part	NOUN
ajlm-916	47	6	of	of	ADP
ajlm-916	47	7	the	the	DET
ajlm-916	47	8	initial	initial	ADJ
ajlm-916	47	9	cluster	cluster	NOUN
ajlm-916	47	10	with	with	ADP
ajlm-916	47	11	a	a	DET
ajlm-916	47	12	maculopapular	maculopapular	ADJ
ajlm-916	47	13	rash	rash	NOUN
ajlm-916	47	14	.	.	PUNCT
ajlm-916	48	1	table	table	NOUN
ajlm-916	48	2	1	1	NUM
ajlm-916	48	3	:	:	PUNCT
ajlm-916	48	4	 	 	SPACE
ajlm-916	48	5	characteristics	characteristic	NOUN
ajlm-916	48	6	of	of	ADP
ajlm-916	48	7	the	the	DET
ajlm-916	48	8	cases	case	NOUN
ajlm-916	48	9	in	in	ADP
ajlm-916	48	10	the	the	DET
ajlm-916	48	11	febrile	febrile	NOUN
ajlm-916	48	12	rash	rash	NOUN
ajlm-916	48	13	illness	illness	NOUN
ajlm-916	48	14	at	at	ADP
ajlm-916	48	15	the	the	DET
ajlm-916	48	16	tertiary	tertiary	ADJ
ajlm-916	48	17	hospital	hospital	NOUN
ajlm-916	48	18	in	in	ADP
ajlm-916	48	19	gauteng	gauteng	PROPN
ajlm-916	48	20	,	,	PUNCT
ajlm-916	48	21	south	south	PROPN
ajlm-916	48	22	africa	africa	PROPN
ajlm-916	48	23	,	,	PUNCT
ajlm-916	48	24	july	july	PROPN
ajlm-916	48	25	2017	2017	NUM
ajlm-916	48	26	.	.	PUNCT
ajlm-916	49	1	measles	measle	NOUN
ajlm-916	49	2	,	,	PUNCT
ajlm-916	49	3	rubella	rubella	NOUN
ajlm-916	49	4	and	and	CCONJ
ajlm-916	49	5	varicella	varicella	NOUN
ajlm-916	49	6	infections	infection	NOUN
ajlm-916	49	7	were	be	AUX
ajlm-916	49	8	excluded	exclude	VERB
ajlm-916	49	9	based	base	VERB
ajlm-916	49	10	on	on	ADP
ajlm-916	49	11	negative	negative	ADJ
ajlm-916	49	12	serological	serological	ADJ
ajlm-916	49	13	testing	testing	NOUN
ajlm-916	49	14	.	.	PUNCT
ajlm-916	50	1	viral	viral	ADJ
ajlm-916	50	2	particles	particle	NOUN
ajlm-916	50	3	consistent	consistent	ADJ
ajlm-916	50	4	with	with	ADP
ajlm-916	50	5	those	those	PRON
ajlm-916	50	6	of	of	ADP
ajlm-916	50	7	the	the	DET
ajlm-916	50	8	herpesviridae	herpesviridae	NOUN
ajlm-916	50	9	family	family	NOUN
ajlm-916	50	10	were	be	AUX
ajlm-916	50	11	seen	see	VERB
ajlm-916	50	12	on	on	ADP
ajlm-916	50	13	electron	electron	NOUN
ajlm-916	50	14	microscopy	microscopy	NOUN
ajlm-916	50	15	of	of	ADP
ajlm-916	50	16	the	the	DET
ajlm-916	50	17	vesicular	vesicular	ADJ
ajlm-916	50	18	fluid	fluid	NOUN
ajlm-916	50	19	,	,	PUNCT
ajlm-916	50	20	while	while	SCONJ
ajlm-916	50	21	no	no	DET
ajlm-916	50	22	virions	virion	NOUN
ajlm-916	50	23	were	be	AUX
ajlm-916	50	24	detected	detect	VERB
ajlm-916	50	25	in	in	ADP
ajlm-916	50	26	the	the	DET
ajlm-916	50	27	scab	scab	NOUN
ajlm-916	50	28	specimen	speciman	NOUN
ajlm-916	50	29	(	(	PUNCT
ajlm-916	50	30	figure	figure	NOUN
ajlm-916	50	31	2	2	NUM
ajlm-916	50	32	)	)	PUNCT
ajlm-916	50	33	.	.	PUNCT
ajlm-916	51	1	based	base	VERB
ajlm-916	51	2	on	on	ADP
ajlm-916	51	3	these	these	DET
ajlm-916	51	4	electron	electron	NOUN
ajlm-916	51	5	microscopy	microscopy	NOUN
ajlm-916	51	6	findings	finding	NOUN
ajlm-916	51	7	,	,	PUNCT
ajlm-916	51	8	further	further	ADJ
ajlm-916	51	9	laboratory	laboratory	NOUN
ajlm-916	51	10	testing	testing	NOUN
ajlm-916	51	11	for	for	ADP
ajlm-916	51	12	herpes	herpe	NOUN
ajlm-916	51	13	viruses	virus	NOUN
ajlm-916	51	14	was	be	AUX
ajlm-916	51	15	conducted	conduct	VERB
ajlm-916	51	16	,	,	PUNCT
ajlm-916	51	17	and	and	CCONJ
ajlm-916	51	18	hsv1	hsv1	PROPN
ajlm-916	51	19	was	be	AUX
ajlm-916	51	20	confirmed	confirm	VERB
ajlm-916	51	21	based	base	VERB
ajlm-916	51	22	on	on	ADP
ajlm-916	51	23	serological	serological	ADJ
ajlm-916	51	24	and	and	CCONJ
ajlm-916	51	25	molecular	molecular	ADJ
ajlm-916	51	26	testing	testing	NOUN
ajlm-916	51	27	.	.	PUNCT
ajlm-916	52	1	the	the	DET
ajlm-916	52	2	medical	medical	ADJ
ajlm-916	52	3	record	record	NOUN
ajlm-916	52	4	review	review	NOUN
ajlm-916	52	5	of	of	ADP
ajlm-916	52	6	other	other	ADJ
ajlm-916	52	7	patients	patient	NOUN
ajlm-916	52	8	in	in	ADP
ajlm-916	52	9	the	the	DET
ajlm-916	52	10	ward	ward	NOUN
ajlm-916	52	11	identified	identify	VERB
ajlm-916	52	12	two	two	NUM
ajlm-916	52	13	other	other	ADJ
ajlm-916	52	14	cases	case	NOUN
ajlm-916	52	15	with	with	ADP
ajlm-916	52	16	a	a	DET
ajlm-916	52	17	documented	document	VERB
ajlm-916	52	18	vesicular	vesicular	ADJ
ajlm-916	52	19	rash	rash	NOUN
ajlm-916	52	20	.	.	PUNCT
ajlm-916	53	1	a	a	DET
ajlm-916	53	2	timeline	timeline	NOUN
ajlm-916	53	3	showing	show	VERB
ajlm-916	53	4	the	the	DET
ajlm-916	53	5	sequence	sequence	NOUN
ajlm-916	53	6	of	of	ADP
ajlm-916	53	7	events	event	NOUN
ajlm-916	53	8	in	in	ADP
ajlm-916	53	9	this	this	DET
ajlm-916	53	10	investigation	investigation	NOUN
ajlm-916	53	11	is	be	AUX
ajlm-916	53	12	shown	show	VERB
ajlm-916	53	13	in	in	ADP
ajlm-916	53	14	figure	figure	NOUN
ajlm-916	53	15	3	3	NUM
ajlm-916	53	16	.	.	PUNCT
ajlm-916	53	17	figure	figure	NOUN
ajlm-916	53	18	2	2	NUM
ajlm-916	53	19	:	:	PUNCT
ajlm-916	53	20	transmission	transmission	NOUN
ajlm-916	53	21	electron	electron	NOUN
ajlm-916	53	22	microscopy	microscopy	NOUN
ajlm-916	53	23	of	of	ADP
ajlm-916	53	24	negatively	negatively	ADV
ajlm-916	53	25	-	-	PUNCT
ajlm-916	53	26	stained	stain	VERB
ajlm-916	53	27	virions	virion	NOUN
ajlm-916	53	28	in	in	ADP
ajlm-916	53	29	vesicular	vesicular	ADJ
ajlm-916	53	30	fluid	fluid	NOUN
ajlm-916	53	31	,	,	PUNCT
ajlm-916	53	32	gauteng	gauteng	PROPN
ajlm-916	53	33	,	,	PUNCT
ajlm-916	53	34	south	south	PROPN
ajlm-916	53	35	africa	africa	PROPN
ajlm-916	53	36	,	,	PUNCT
ajlm-916	53	37	july	july	PROPN
ajlm-916	53	38	2017	2017	NUM
ajlm-916	53	39	.	.	PUNCT
ajlm-916	54	1	(	(	PUNCT
ajlm-916	54	2	a	a	X
ajlm-916	54	3	)	)	PUNCT
ajlm-916	54	4	and	and	CCONJ
ajlm-916	54	5	(	(	PUNCT
ajlm-916	54	6	b	b	NOUN
ajlm-916	54	7	)	)	PUNCT
ajlm-916	54	8	show	show	VERB
ajlm-916	54	9	typical	typical	ADJ
ajlm-916	54	10	herpesviridae	herpesviridae	NOUN
ajlm-916	54	11	particles	particle	NOUN
ajlm-916	54	12	with	with	ADP
ajlm-916	54	13	an	an	DET
ajlm-916	54	14	icosahedral	icosahedral	ADJ
ajlm-916	54	15	nucleocapsid	nucleocapsid	NOUN
ajlm-916	54	16	(	(	PUNCT
ajlm-916	54	17	2	2	NUM
ajlm-916	54	18	)	)	PUNCT
ajlm-916	54	19	surrounded	surround	VERB
ajlm-916	54	20	by	by	ADP
ajlm-916	54	21	a	a	DET
ajlm-916	54	22	loose	loose	ADJ
ajlm-916	54	23	envelope	envelope	NOUN
ajlm-916	54	24	(	(	PUNCT
ajlm-916	54	25	1	1	NUM
ajlm-916	54	26	)	)	PUNCT
ajlm-916	54	27	.	.	PUNCT
ajlm-916	55	1	during	during	ADP
ajlm-916	55	2	collection	collection	NOUN
ajlm-916	55	3	and	and	CCONJ
ajlm-916	55	4	processing	processing	NOUN
ajlm-916	55	5	of	of	ADP
ajlm-916	55	6	vesicular	vesicular	ADJ
ajlm-916	55	7	fluids	fluid	NOUN
ajlm-916	55	8	,	,	PUNCT
ajlm-916	55	9	the	the	DET
ajlm-916	55	10	fragile	fragile	ADJ
ajlm-916	55	11	envelope	envelope	NOUN
ajlm-916	55	12	frequently	frequently	ADV
ajlm-916	55	13	ruptures	rupture	VERB
ajlm-916	55	14	to	to	PART
ajlm-916	55	15	release	release	VERB
ajlm-916	55	16	the	the	DET
ajlm-916	55	17	nucleocapsid	nucleocapsid	NOUN
ajlm-916	55	18	,	,	PUNCT
ajlm-916	55	19	which	which	PRON
ajlm-916	55	20	can	can	AUX
ajlm-916	55	21	be	be	AUX
ajlm-916	55	22	seen	see	VERB
ajlm-916	55	23	to	to	PART
ajlm-916	55	24	be	be	AUX
ajlm-916	55	25	composed	compose	VERB
ajlm-916	55	26	of	of	ADP
ajlm-916	55	27	characteristic	characteristic	ADJ
ajlm-916	55	28	cylindrical	cylindrical	ADJ
ajlm-916	55	29	capsomers	capsomer	NOUN
ajlm-916	55	30	(	(	PUNCT
ajlm-916	55	31	inset	inset	NOUN
ajlm-916	55	32	b	b	NOUN
ajlm-916	55	33	)	)	PUNCT
ajlm-916	55	34	.	.	PUNCT
ajlm-916	56	1	figure	figure	VERB
ajlm-916	56	2	3	3	NUM
ajlm-916	56	3	:	:	PUNCT
ajlm-916	56	4	sequence	sequence	NOUN
ajlm-916	56	5	of	of	ADP
ajlm-916	56	6	events	event	NOUN
ajlm-916	56	7	during	during	ADP
ajlm-916	56	8	the	the	DET
ajlm-916	56	9	investigation	investigation	NOUN
ajlm-916	56	10	,	,	PUNCT
ajlm-916	56	11	gauteng	gauteng	PROPN
ajlm-916	56	12	,	,	PUNCT
ajlm-916	56	13	south	south	PROPN
ajlm-916	56	14	africa	africa	PROPN
ajlm-916	56	15	,	,	PUNCT
ajlm-916	56	16	july	july	PROPN
ajlm-916	56	17	2017	2017	NUM
ajlm-916	56	18	.	.	PUNCT
ajlm-916	57	1	management	management	NOUN
ajlm-916	57	2	and	and	CCONJ
ajlm-916	57	3	outcomes	outcome	NOUN
ajlm-916	57	4	due	due	ADP
ajlm-916	57	5	to	to	ADP
ajlm-916	57	6	the	the	DET
ajlm-916	57	7	initial	initial	ADJ
ajlm-916	57	8	differential	differential	ADJ
ajlm-916	57	9	diagnosis	diagnosis	NOUN
ajlm-916	57	10	of	of	ADP
ajlm-916	57	11	measles	measle	NOUN
ajlm-916	57	12	,	,	PUNCT
ajlm-916	57	13	cases	case	NOUN
ajlm-916	57	14	were	be	AUX
ajlm-916	57	15	given	give	VERB
ajlm-916	57	16	vitamin	vitamin	NOUN
ajlm-916	57	17	a	a	PRON
ajlm-916	57	18	,	,	PUNCT
ajlm-916	57	19	and	and	CCONJ
ajlm-916	57	20	measles	measle	NOUN
ajlm-916	57	21	vaccine	vaccine	NOUN
ajlm-916	57	22	was	be	AUX
ajlm-916	57	23	administered	administer	VERB
ajlm-916	57	24	to	to	ADP
ajlm-916	57	25	all	all	DET
ajlm-916	57	26	ward	ward	NOUN
ajlm-916	57	27	contacts	contact	NOUN
ajlm-916	57	28	below	below	ADP
ajlm-916	57	29	the	the	DET
ajlm-916	57	30	age	age	NOUN
ajlm-916	57	31	of	of	ADP
ajlm-916	57	32	5	5	NUM
ajlm-916	57	33	years	year	NOUN
ajlm-916	57	34	.	.	PUNCT
ajlm-916	58	1	all	all	PRON
ajlm-916	58	2	of	of	ADP
ajlm-916	58	3	the	the	DET
ajlm-916	58	4	cases	case	NOUN
ajlm-916	58	5	recovered	recover	VERB
ajlm-916	58	6	completely	completely	ADV
ajlm-916	58	7	without	without	ADP
ajlm-916	58	8	any	any	DET
ajlm-916	58	9	complications	complication	NOUN
ajlm-916	58	10	.	.	PUNCT
ajlm-916	59	1	discussion	discussion	NOUN
ajlm-916	59	2	the	the	DET
ajlm-916	59	3	presentation	presentation	NOUN
ajlm-916	59	4	of	of	ADP
ajlm-916	59	5	hsv1	hsv1	PROPN
ajlm-916	59	6	infection	infection	NOUN
ajlm-916	59	7	in	in	ADP
ajlm-916	59	8	this	this	DET
ajlm-916	59	9	cluster	cluster	NOUN
ajlm-916	59	10	was	be	AUX
ajlm-916	59	11	atypical	atypical	ADJ
ajlm-916	59	12	for	for	ADP
ajlm-916	59	13	several	several	ADJ
ajlm-916	59	14	reasons	reason	NOUN
ajlm-916	59	15	.	.	PUNCT
ajlm-916	60	1	firstly	firstly	ADV
ajlm-916	60	2	,	,	PUNCT
ajlm-916	60	3	hsv	hsv	PROPN
ajlm-916	60	4	infections	infection	NOUN
ajlm-916	60	5	are	be	AUX
ajlm-916	60	6	usually	usually	ADV
ajlm-916	60	7	associated	associate	VERB
ajlm-916	60	8	with	with	ADP
ajlm-916	60	9	more	more	ADV
ajlm-916	60	10	extensive	extensive	ADJ
ajlm-916	60	11	burns.4,5,6	burns.4,5,6	NOUN
ajlm-916	60	12	all	all	PRON
ajlm-916	60	13	of	of	ADP
ajlm-916	60	14	the	the	DET
ajlm-916	60	15	cases	case	NOUN
ajlm-916	60	16	in	in	ADP
ajlm-916	60	17	this	this	DET
ajlm-916	60	18	cluster	cluster	NOUN
ajlm-916	60	19	had	have	VERB
ajlm-916	60	20	partial	partial	ADJ
ajlm-916	60	21	thickness	thickness	NOUN
ajlm-916	60	22	burn	burn	VERB
ajlm-916	60	23	wounds	wound	NOUN
ajlm-916	60	24	that	that	PRON
ajlm-916	60	25	were	be	AUX
ajlm-916	60	26	≤	≤	NUM
ajlm-916	60	27	20	20	NUM
ajlm-916	60	28	%	%	NOUN
ajlm-916	60	29	of	of	ADP
ajlm-916	60	30	the	the	DET
ajlm-916	60	31	total	total	ADJ
ajlm-916	60	32	body	body	NOUN
ajlm-916	60	33	surface	surface	NOUN
ajlm-916	60	34	area	area	NOUN
ajlm-916	60	35	.	.	PUNCT
ajlm-916	61	1	secondly	secondly	ADV
ajlm-916	61	2	,	,	PUNCT
ajlm-916	61	3	unlike	unlike	ADP
ajlm-916	61	4	the	the	DET
ajlm-916	61	5	commonly	commonly	ADV
ajlm-916	61	6	described	describe	VERB
ajlm-916	61	7	distribution	distribution	NOUN
ajlm-916	61	8	of	of	ADP
ajlm-916	61	9	the	the	DET
ajlm-916	61	10	vesicular	vesicular	ADJ
ajlm-916	61	11	rash	rash	NOUN
ajlm-916	61	12	within	within	ADP
ajlm-916	61	13	or	or	CCONJ
ajlm-916	61	14	around	around	ADP
ajlm-916	61	15	the	the	DET
ajlm-916	61	16	wound	wound	NOUN
ajlm-916	61	17	margins	margin	NOUN
ajlm-916	61	18	,	,	PUNCT
ajlm-916	61	19	the	the	DET
ajlm-916	61	20	lesions	lesion	NOUN
ajlm-916	61	21	occurred	occur	VERB
ajlm-916	61	22	peripherally	peripherally	ADV
ajlm-916	61	23	from	from	ADP
ajlm-916	61	24	the	the	DET
ajlm-916	61	25	burn	burn	NOUN
ajlm-916	61	26	wounds	wound	NOUN
ajlm-916	61	27	in	in	ADP
ajlm-916	61	28	all	all	PRON
ajlm-916	61	29	except	except	SCONJ
ajlm-916	61	30	one	one	NUM
ajlm-916	61	31	of	of	ADP
ajlm-916	61	32	the	the	DET
ajlm-916	61	33	cases	case	NOUN
ajlm-916	61	34	.	.	PUNCT
ajlm-916	62	1	the	the	DET
ajlm-916	62	2	vesicular	vesicular	ADJ
ajlm-916	62	3	rash	rash	NOUN
ajlm-916	62	4	was	be	AUX
ajlm-916	62	5	also	also	ADV
ajlm-916	62	6	distributed	distribute	VERB
ajlm-916	62	7	on	on	ADP
ajlm-916	62	8	the	the	DET
ajlm-916	62	9	limbs	limb	NOUN
ajlm-916	62	10	and	and	CCONJ
ajlm-916	62	11	torso	torso	NOUN
ajlm-916	62	12	in	in	ADP
ajlm-916	62	13	some	some	PRON
ajlm-916	62	14	of	of	ADP
ajlm-916	62	15	the	the	DET
ajlm-916	62	16	cases	case	NOUN
ajlm-916	62	17	,	,	PUNCT
ajlm-916	62	18	with	with	ADP
ajlm-916	62	19	only	only	ADV
ajlm-916	62	20	one	one	NUM
ajlm-916	62	21	case	case	NOUN
ajlm-916	62	22	having	have	VERB
ajlm-916	62	23	orolabial	orolabial	ADJ
ajlm-916	62	24	involvement	involvement	NOUN
ajlm-916	62	25	.	.	PUNCT
ajlm-916	63	1	the	the	DET
ajlm-916	63	2	fact	fact	NOUN
ajlm-916	63	3	that	that	SCONJ
ajlm-916	63	4	no	no	DET
ajlm-916	63	5	virions	virion	NOUN
ajlm-916	63	6	were	be	AUX
ajlm-916	63	7	observed	observe	VERB
ajlm-916	63	8	in	in	ADP
ajlm-916	63	9	the	the	DET
ajlm-916	63	10	scab	scab	NOUN
ajlm-916	63	11	using	use	VERB
ajlm-916	63	12	transmission	transmission	NOUN
ajlm-916	63	13	electron	electron	NOUN
ajlm-916	63	14	microscopy	microscopy	NOUN
ajlm-916	63	15	is	be	AUX
ajlm-916	63	16	in	in	ADP
ajlm-916	63	17	keeping	keep	VERB
ajlm-916	63	18	with	with	ADP
ajlm-916	63	19	the	the	DET
ajlm-916	63	20	presentation	presentation	NOUN
ajlm-916	63	21	of	of	ADP
ajlm-916	63	22	herpes	herpe	NOUN
ajlm-916	63	23	viruses	virus	NOUN
ajlm-916	63	24	.	.	PUNCT
ajlm-916	64	1	this	this	DET
ajlm-916	64	2	finding	finding	NOUN
ajlm-916	64	3	also	also	ADV
ajlm-916	64	4	aided	aid	VERB
ajlm-916	64	5	in	in	ADP
ajlm-916	64	6	the	the	DET
ajlm-916	64	7	exclusion	exclusion	NOUN
ajlm-916	64	8	of	of	ADP
ajlm-916	64	9	pox	pox	NOUN
ajlm-916	64	10	viruses	virus	NOUN
ajlm-916	64	11	,	,	PUNCT
ajlm-916	64	12	as	as	SCONJ
ajlm-916	64	13	the	the	DET
ajlm-916	64	14	latter	latter	ADJ
ajlm-916	64	15	are	be	AUX
ajlm-916	64	16	typically	typically	ADV
ajlm-916	64	17	found	find	VERB
ajlm-916	64	18	in	in	ADP
ajlm-916	64	19	the	the	DET
ajlm-916	64	20	crusted	crust	VERB
ajlm-916	64	21	lesions	lesion	NOUN
ajlm-916	64	22	.	.	PUNCT
ajlm-916	65	1	pox	pox	NOUN
ajlm-916	65	2	viruses	virus	NOUN
ajlm-916	65	3	are	be	AUX
ajlm-916	65	4	also	also	ADV
ajlm-916	65	5	more	more	ADV
ajlm-916	65	6	robust	robust	ADJ
ajlm-916	65	7	and	and	CCONJ
ajlm-916	65	8	long	long	ADV
ajlm-916	65	9	-	-	PUNCT
ajlm-916	65	10	lived	live	VERB
ajlm-916	65	11	compared	compare	VERB
ajlm-916	65	12	to	to	ADP
ajlm-916	65	13	herpes	herpe	NOUN
ajlm-916	65	14	viruses	virus	NOUN
ajlm-916	65	15	which	which	PRON
ajlm-916	65	16	have	have	VERB
ajlm-916	65	17	more	more	ADV
ajlm-916	65	18	delicate	delicate	ADJ
ajlm-916	65	19	and	and	CCONJ
ajlm-916	65	20	pleomorphic	pleomorphic	ADJ
ajlm-916	65	21	envelopes.9	envelopes.9	NOUN
ajlm-916	65	22	the	the	DET
ajlm-916	65	23	incidence	incidence	NOUN
ajlm-916	65	24	of	of	ADP
ajlm-916	65	25	hsv1	hsv1	PROPN
ajlm-916	65	26	infections	infection	NOUN
ajlm-916	65	27	have	have	AUX
ajlm-916	65	28	been	be	AUX
ajlm-916	65	29	estimated	estimate	VERB
ajlm-916	65	30	to	to	PART
ajlm-916	65	31	occur	occur	VERB
ajlm-916	65	32	more	more	ADV
ajlm-916	65	33	commonly	commonly	ADV
ajlm-916	65	34	in	in	ADP
ajlm-916	65	35	the	the	DET
ajlm-916	65	36	0–4	0–4	NUM
ajlm-916	65	37	year	year	NOUN
ajlm-916	65	38	age	age	NOUN
ajlm-916	65	39	group	group	NOUN
ajlm-916	65	40	in	in	ADP
ajlm-916	65	41	both	both	DET
ajlm-916	65	42	boys	boy	NOUN
ajlm-916	65	43	and	and	CCONJ
ajlm-916	65	44	girls	girl	NOUN
ajlm-916	65	45	in	in	ADP
ajlm-916	65	46	africa.7	africa.7	PROPN
ajlm-916	65	47	due	due	ADP
ajlm-916	65	48	to	to	ADP
ajlm-916	65	49	the	the	DET
ajlm-916	65	50	spatial	spatial	ADJ
ajlm-916	65	51	and	and	CCONJ
ajlm-916	65	52	temporal	temporal	ADJ
ajlm-916	65	53	association	association	NOUN
ajlm-916	65	54	of	of	ADP
ajlm-916	65	55	the	the	DET
ajlm-916	65	56	cases	case	NOUN
ajlm-916	65	57	,	,	PUNCT
ajlm-916	65	58	primary	primary	ADJ
ajlm-916	65	59	nosocomial	nosocomial	ADJ
ajlm-916	65	60	infection	infection	NOUN
ajlm-916	65	61	is	be	AUX
ajlm-916	65	62	the	the	DET
ajlm-916	65	63	likely	likely	ADJ
ajlm-916	65	64	mode	mode	NOUN
ajlm-916	65	65	of	of	ADP
ajlm-916	65	66	transmission	transmission	NOUN
ajlm-916	65	67	.	.	PUNCT
ajlm-916	66	1	however	however	ADV
ajlm-916	66	2	,	,	PUNCT
ajlm-916	66	3	due	due	ADP
ajlm-916	66	4	to	to	ADP
ajlm-916	66	5	a	a	DET
ajlm-916	66	6	high	high	ADJ
ajlm-916	66	7	hsv1	hsv1	PROPN
ajlm-916	66	8	seroprevalence	seroprevalence	NOUN
ajlm-916	66	9	in	in	ADP
ajlm-916	66	10	our	our	PRON
ajlm-916	66	11	study	study	NOUN
ajlm-916	66	12	setting	setting	NOUN
ajlm-916	66	13	,	,	PUNCT
ajlm-916	66	14	the	the	DET
ajlm-916	66	15	reactivation	reactivation	NOUN
ajlm-916	66	16	of	of	ADP
ajlm-916	66	17	latent	latent	PROPN
ajlm-916	66	18	hsv1	hsv1	PROPN
ajlm-916	66	19	is	be	AUX
ajlm-916	66	20	also	also	ADV
ajlm-916	66	21	a	a	DET
ajlm-916	66	22	likely	likely	ADJ
ajlm-916	66	23	possibility	possibility	NOUN
ajlm-916	66	24	.	.	PUNCT
ajlm-916	67	1	hsv	hsv	PROPN
ajlm-916	67	2	is	be	AUX
ajlm-916	67	3	transmitted	transmit	VERB
ajlm-916	67	4	through	through	ADP
ajlm-916	67	5	contact	contact	NOUN
ajlm-916	67	6	with	with	ADP
ajlm-916	67	7	vesicular	vesicular	ADJ
ajlm-916	67	8	lesions	lesion	NOUN
ajlm-916	67	9	,	,	PUNCT
ajlm-916	67	10	and	and	CCONJ
ajlm-916	67	11	this	this	PRON
ajlm-916	67	12	was	be	AUX
ajlm-916	67	13	the	the	DET
ajlm-916	67	14	most	most	ADV
ajlm-916	67	15	likely	likely	ADJ
ajlm-916	67	16	mode	mode	NOUN
ajlm-916	67	17	of	of	ADP
ajlm-916	67	18	transmission	transmission	NOUN
ajlm-916	67	19	in	in	ADP
ajlm-916	67	20	this	this	DET
ajlm-916	67	21	cluster	cluster	NOUN
ajlm-916	67	22	.	.	PUNCT
ajlm-916	68	1	this	this	PRON
ajlm-916	68	2	highlights	highlight	VERB
ajlm-916	68	3	the	the	DET
ajlm-916	68	4	importance	importance	NOUN
ajlm-916	68	5	of	of	ADP
ajlm-916	68	6	adhering	adhere	VERB
ajlm-916	68	7	to	to	ADP
ajlm-916	68	8	standard	standard	ADJ
ajlm-916	68	9	precautions	precaution	NOUN
ajlm-916	68	10	,	,	PUNCT
ajlm-916	68	11	particularly	particularly	ADV
ajlm-916	68	12	in	in	ADP
ajlm-916	68	13	burns	burn	NOUN
ajlm-916	68	14	patients	patient	NOUN
ajlm-916	68	15	in	in	ADP
ajlm-916	68	16	whom	whom	PRON
ajlm-916	68	17	the	the	DET
ajlm-916	68	18	protective	protective	ADJ
ajlm-916	68	19	skin	skin	NOUN
ajlm-916	68	20	barrier	barrier	NOUN
ajlm-916	68	21	has	have	AUX
ajlm-916	68	22	been	be	AUX
ajlm-916	68	23	compromised	compromise	VERB
ajlm-916	68	24	.	.	PUNCT
ajlm-916	69	1	we	we	PRON
ajlm-916	69	2	postulate	postulate	VERB
ajlm-916	69	3	that	that	SCONJ
ajlm-916	69	4	the	the	DET
ajlm-916	69	5	communal	communal	ADJ
ajlm-916	69	6	dressing	dressing	NOUN
ajlm-916	69	7	room	room	NOUN
ajlm-916	69	8	,	,	PUNCT
ajlm-916	69	9	where	where	SCONJ
ajlm-916	69	10	most	most	ADJ
ajlm-916	69	11	of	of	ADP
ajlm-916	69	12	the	the	DET
ajlm-916	69	13	cases	case	NOUN
ajlm-916	69	14	had	have	VERB
ajlm-916	69	15	their	their	PRON
ajlm-916	69	16	wounds	wound	NOUN
ajlm-916	69	17	dressed	dress	VERB
ajlm-916	69	18	prior	prior	ADV
ajlm-916	69	19	to	to	ADP
ajlm-916	69	20	the	the	DET
ajlm-916	69	21	onset	onset	NOUN
ajlm-916	69	22	of	of	ADP
ajlm-916	69	23	the	the	DET
ajlm-916	69	24	illness	illness	NOUN
ajlm-916	69	25	,	,	PUNCT
ajlm-916	69	26	was	be	AUX
ajlm-916	69	27	most	most	ADV
ajlm-916	69	28	likely	likely	ADJ
ajlm-916	69	29	where	where	SCONJ
ajlm-916	69	30	transmission	transmission	NOUN
ajlm-916	69	31	occurred	occur	VERB
ajlm-916	69	32	.	.	PUNCT
ajlm-916	70	1	limitations	limitation	NOUN
ajlm-916	70	2	limitations	limitation	NOUN
ajlm-916	70	3	of	of	ADP
ajlm-916	70	4	this	this	DET
ajlm-916	70	5	outbreak	outbreak	NOUN
ajlm-916	70	6	investigation	investigation	NOUN
ajlm-916	70	7	included	include	VERB
ajlm-916	70	8	delayed	delay	VERB
ajlm-916	70	9	identification	identification	NOUN
ajlm-916	70	10	of	of	ADP
ajlm-916	70	11	two	two	NUM
ajlm-916	70	12	probable	probable	ADJ
ajlm-916	70	13	cases	case	NOUN
ajlm-916	70	14	found	find	VERB
ajlm-916	70	15	on	on	ADP
ajlm-916	70	16	the	the	DET
ajlm-916	70	17	medical	medical	ADJ
ajlm-916	70	18	records	record	NOUN
ajlm-916	70	19	review	review	VERB
ajlm-916	70	20	.	.	PUNCT
ajlm-916	71	1	as	as	SCONJ
ajlm-916	71	2	their	their	PRON
ajlm-916	71	3	vesicular	vesicular	ADJ
ajlm-916	71	4	lesions	lesion	NOUN
ajlm-916	71	5	had	have	AUX
ajlm-916	71	6	already	already	ADV
ajlm-916	71	7	healed	heal	VERB
ajlm-916	71	8	,	,	PUNCT
ajlm-916	71	9	appropriate	appropriate	ADJ
ajlm-916	71	10	samples	sample	NOUN
ajlm-916	71	11	were	be	AUX
ajlm-916	71	12	not	not	PART
ajlm-916	71	13	available	available	ADJ
ajlm-916	71	14	for	for	ADP
ajlm-916	71	15	laboratory	laboratory	NOUN
ajlm-916	71	16	confirmation	confirmation	NOUN
ajlm-916	71	17	of	of	ADP
ajlm-916	71	18	hsv1	hsv1	PROPN
ajlm-916	71	19	.	.	PUNCT
ajlm-916	72	1	in	in	ADP
ajlm-916	72	2	addition	addition	NOUN
ajlm-916	72	3	,	,	PUNCT
ajlm-916	72	4	comparative	comparative	ADJ
ajlm-916	72	5	sequencing	sequencing	NOUN
ajlm-916	72	6	in	in	ADP
ajlm-916	72	7	the	the	DET
ajlm-916	72	8	three	three	NUM
ajlm-916	72	9	cases	case	NOUN
ajlm-916	72	10	with	with	ADP
ajlm-916	72	11	laboratory	laboratory	NOUN
ajlm-916	72	12	-	-	PUNCT
ajlm-916	72	13	confirmed	confirm	VERB
ajlm-916	72	14	hsv1	hsv1	PROPN
ajlm-916	72	15	could	could	AUX
ajlm-916	72	16	not	not	PART
ajlm-916	72	17	be	be	AUX
ajlm-916	72	18	conducted	conduct	VERB
ajlm-916	72	19	due	due	ADJ
ajlm-916	72	20	to	to	ADP
ajlm-916	72	21	unavailability	unavailability	NOUN
ajlm-916	72	22	of	of	ADP
ajlm-916	72	23	residual	residual	ADJ
ajlm-916	72	24	specimens	specimen	NOUN
ajlm-916	72	25	.	.	PUNCT
ajlm-916	72	26	conclusion	conclusion	NOUN
ajlm-916	72	27	although	although	SCONJ
ajlm-916	72	28	hsv1	hsv1	PROPN
ajlm-916	72	29	infection	infection	NOUN
ajlm-916	72	30	in	in	ADP
ajlm-916	72	31	burns	burn	NOUN
ajlm-916	72	32	patients	patient	NOUN
ajlm-916	72	33	has	have	AUX
ajlm-916	72	34	been	be	AUX
ajlm-916	72	35	described	describe	VERB
ajlm-916	72	36	in	in	ADP
ajlm-916	72	37	other	other	ADJ
ajlm-916	72	38	international	international	ADJ
ajlm-916	72	39	settings	setting	NOUN
ajlm-916	72	40	,	,	PUNCT
ajlm-916	72	41	a	a	DET
ajlm-916	72	42	literature	literature	NOUN
ajlm-916	72	43	review	review	NOUN
ajlm-916	72	44	showed	show	VERB
ajlm-916	72	45	that	that	SCONJ
ajlm-916	72	46	the	the	DET
ajlm-916	72	47	illness	illness	NOUN
ajlm-916	72	48	has	have	AUX
ajlm-916	72	49	not	not	PART
ajlm-916	72	50	been	be	AUX
ajlm-916	72	51	well	well	ADV
ajlm-916	72	52	described	describe	VERB
ajlm-916	72	53	in	in	ADP
ajlm-916	72	54	the	the	DET
ajlm-916	72	55	south	south	ADJ
ajlm-916	72	56	african	african	ADJ
ajlm-916	72	57	setting	setting	NOUN
ajlm-916	72	58	.	.	PUNCT
ajlm-916	73	1	treatment	treatment	NOUN
ajlm-916	73	2	of	of	ADP
ajlm-916	73	3	laboratory	laboratory	NOUN
ajlm-916	73	4	-	-	PUNCT
ajlm-916	73	5	confirmed	confirm	VERB
ajlm-916	73	6	hsv	hsv	NOUN
ajlm-916	73	7	infection	infection	NOUN
ajlm-916	73	8	includes	include	VERB
ajlm-916	73	9	intravenous	intravenous	ADJ
ajlm-916	73	10	acyclovir	acyclovir	PROPN
ajlm-916	73	11	at	at	ADP
ajlm-916	73	12	5–10	5–10	PROPN
ajlm-916	73	13	mg	mg	PROPN
ajlm-916	73	14	/	/	SYM
ajlm-916	73	15	kg	kg	PROPN
ajlm-916	73	16	8	8	NUM
ajlm-916	73	17	hourly	hourly	ADV
ajlm-916	73	18	for	for	ADP
ajlm-916	73	19	10–14	10–14	NUM
ajlm-916	73	20	days	day	NOUN
ajlm-916	73	21	,	,	PUNCT
ajlm-916	73	22	with	with	ADP
ajlm-916	73	23	or	or	CCONJ
ajlm-916	73	24	without	without	ADP
ajlm-916	73	25	the	the	DET
ajlm-916	73	26	addition	addition	NOUN
ajlm-916	73	27	of	of	ADP
ajlm-916	73	28	topical	topical	NOUN
ajlm-916	73	29	acyclovir.4,5,6	acyclovir.4,5,6	SCONJ
ajlm-916	73	30	this	this	DET
ajlm-916	73	31	management	management	NOUN
ajlm-916	73	32	was	be	AUX
ajlm-916	73	33	not	not	PART
ajlm-916	73	34	prescribed	prescribe	VERB
ajlm-916	73	35	for	for	ADP
ajlm-916	73	36	the	the	DET
ajlm-916	73	37	cases	case	NOUN
ajlm-916	73	38	in	in	ADP
ajlm-916	73	39	this	this	DET
ajlm-916	73	40	cluster	cluster	NOUN
ajlm-916	73	41	,	,	PUNCT
ajlm-916	73	42	but	but	CCONJ
ajlm-916	73	43	there	there	PRON
ajlm-916	73	44	were	be	VERB
ajlm-916	73	45	subsequently	subsequently	ADV
ajlm-916	73	46	no	no	DET
ajlm-916	73	47	complications	complication	NOUN
ajlm-916	73	48	in	in	ADP
ajlm-916	73	49	any	any	PRON
ajlm-916	73	50	of	of	ADP
ajlm-916	73	51	the	the	DET
ajlm-916	73	52	patients	patient	NOUN
ajlm-916	73	53	.	.	PUNCT
ajlm-916	74	1	prevention	prevention	NOUN
ajlm-916	74	2	of	of	ADP
ajlm-916	74	3	the	the	DET
ajlm-916	74	4	nosocomial	nosocomial	ADJ
ajlm-916	74	5	spread	spread	NOUN
ajlm-916	74	6	of	of	ADP
ajlm-916	74	7	hsv1	hsv1	PROPN
ajlm-916	74	8	includes	include	VERB
ajlm-916	74	9	isolating	isolate	VERB
ajlm-916	74	10	infected	infected	ADJ
ajlm-916	74	11	patients	patient	NOUN
ajlm-916	74	12	and	and	CCONJ
ajlm-916	74	13	avoiding	avoid	VERB
ajlm-916	74	14	the	the	DET
ajlm-916	74	15	use	use	NOUN
ajlm-916	74	16	of	of	ADP
ajlm-916	74	17	communal	communal	ADJ
ajlm-916	74	18	facilities	facility	NOUN
ajlm-916	74	19	by	by	ADP
ajlm-916	74	20	cases	case	NOUN
ajlm-916	74	21	until	until	SCONJ
ajlm-916	74	22	the	the	DET
ajlm-916	74	23	vesicular	vesicular	ADJ
ajlm-916	74	24	lesions	lesion	NOUN
ajlm-916	74	25	have	have	AUX
ajlm-916	74	26	healed	heal	VERB
ajlm-916	74	27	.	.	PUNCT
ajlm-916	75	1	surgery	surgery	NOUN
ajlm-916	75	2	to	to	ADP
ajlm-916	75	3	infected	infect	VERB
ajlm-916	75	4	wounds	wound	NOUN
ajlm-916	75	5	should	should	AUX
ajlm-916	75	6	also	also	ADV
ajlm-916	75	7	be	be	AUX
ajlm-916	75	8	deferred	defer	VERB
ajlm-916	75	9	until	until	SCONJ
ajlm-916	75	10	vesicles	vesicle	NOUN
ajlm-916	75	11	have	have	AUX
ajlm-916	75	12	resolved	resolve	VERB
ajlm-916	75	13	.	.	PUNCT
ajlm-916	76	1	acknowledgements	acknowledgement	NOUN
ajlm-916	76	2	we	we	PRON
ajlm-916	76	3	would	would	AUX
ajlm-916	76	4	like	like	VERB
ajlm-916	76	5	to	to	PART
ajlm-916	76	6	thank	thank	VERB
ajlm-916	76	7	the	the	DET
ajlm-916	76	8	laboratory	laboratory	NOUN
ajlm-916	76	9	staff	staff	NOUN
ajlm-916	76	10	of	of	ADP
ajlm-916	76	11	the	the	DET
ajlm-916	76	12	national	national	PROPN
ajlm-916	76	13	health	health	PROPN
ajlm-916	76	14	laboratory	laboratory	PROPN
ajlm-916	76	15	service	service	NOUN
ajlm-916	76	16	and	and	CCONJ
ajlm-916	76	17	lancet	lancet	NOUN
ajlm-916	76	18	laboratories	laboratory	NOUN
ajlm-916	76	19	for	for	ADP
ajlm-916	76	20	providing	provide	VERB
ajlm-916	76	21	the	the	DET
ajlm-916	76	22	serological	serological	ADJ
ajlm-916	76	23	and	and	CCONJ
ajlm-916	76	24	molecular	molecular	ADJ
ajlm-916	76	25	testing	testing	NOUN
ajlm-916	76	26	.	.	PUNCT
ajlm-916	77	1	competing	compete	VERB
ajlm-916	77	2	interests	interest	NOUN
ajlm-916	77	3	the	the	DET
ajlm-916	77	4	authors	author	NOUN
ajlm-916	77	5	have	have	VERB
ajlm-916	77	6	none	none	NOUN
ajlm-916	77	7	to	to	PART
ajlm-916	77	8	declare	declare	VERB
ajlm-916	77	9	.	.	PUNCT
ajlm-916	78	1	authors	author	NOUN
ajlm-916	78	2	’	'	PUNCT
ajlm-916	78	3	contributions	contribution	NOUN
ajlm-916	78	4	all	all	DET
ajlm-916	78	5	authors	author	NOUN
ajlm-916	78	6	contributed	contribute	VERB
ajlm-916	78	7	to	to	ADP
ajlm-916	78	8	the	the	DET
ajlm-916	78	9	intellectual	intellectual	ADJ
ajlm-916	78	10	content	content	NOUN
ajlm-916	78	11	of	of	ADP
ajlm-916	78	12	the	the	DET
ajlm-916	78	13	article	article	NOUN
ajlm-916	78	14	as	as	ADV
ajlm-916	78	15	well	well	ADV
ajlm-916	78	16	as	as	ADP
ajlm-916	78	17	in	in	ADP
ajlm-916	78	18	drafting	draft	VERB
ajlm-916	78	19	and	and	CCONJ
ajlm-916	78	20	reviewing	review	VERB
ajlm-916	78	21	the	the	DET
ajlm-916	78	22	manuscript	manuscript	NOUN
ajlm-916	78	23	.	.	PUNCT
ajlm-916	79	1	m.l.s	m.l.s	NOUN
ajlm-916	79	2	.	.	PUNCT
ajlm-916	80	1	and	and	CCONJ
ajlm-916	80	2	k.m	k.m	PROPN
ajlm-916	80	3	.	.	PROPN
ajlm-916	80	4	conceptualised	conceptualise	VERB
ajlm-916	80	5	the	the	DET
ajlm-916	80	6	project	project	NOUN
ajlm-916	80	7	.	.	PUNCT
ajlm-916	81	1	m.l.s	m.l.s	NOUN
ajlm-916	81	2	.	.	PROPN
ajlm-916	82	1	performed	perform	VERB
ajlm-916	82	2	the	the	DET
ajlm-916	82	3	field	field	NOUN
ajlm-916	82	4	epidemiology	epidemiology	NOUN
ajlm-916	82	5	.	.	PUNCT
ajlm-916	83	1	m.b	m.b	PROPN
ajlm-916	83	2	.	.	PROPN
ajlm-916	83	3	performed	perform	VERB
ajlm-916	83	4	the	the	DET
ajlm-916	83	5	electron	electron	NOUN
ajlm-916	83	6	microscopy	microscopy	NOUN
ajlm-916	83	7	.	.	PUNCT
ajlm-916	84	1	all	all	DET
ajlm-916	84	2	authors	author	NOUN
ajlm-916	84	3	(	(	PUNCT
ajlm-916	84	4	m.l.s	m.l.s	NOUN
ajlm-916	84	5	.	.	PROPN
ajlm-916	84	6	,	,	PUNCT
ajlm-916	84	7	a.s	a.s	PROPN
ajlm-916	84	8	.	.	PROPN
ajlm-916	84	9	,	,	PUNCT
ajlm-916	84	10	m.b	m.b	PROPN
ajlm-916	84	11	.	.	PROPN
ajlm-916	84	12	,	,	PUNCT
ajlm-916	84	13	k.m	k.m	PROPN
ajlm-916	84	14	.	.	PROPN
ajlm-916	84	15	)	)	PUNCT
ajlm-916	84	16	made	make	VERB
ajlm-916	84	17	contributions	contribution	NOUN
ajlm-916	84	18	to	to	ADP
ajlm-916	84	19	the	the	DET
ajlm-916	84	20	acquisition	acquisition	NOUN
ajlm-916	84	21	,	,	PUNCT
ajlm-916	84	22	analysis	analysis	NOUN
ajlm-916	84	23	and	and	CCONJ
ajlm-916	84	24	interpretation	interpretation	NOUN
ajlm-916	84	25	of	of	ADP
ajlm-916	84	26	data	datum	NOUN
ajlm-916	84	27	for	for	ADP
ajlm-916	84	28	the	the	DET
ajlm-916	84	29	work	work	NOUN
ajlm-916	84	30	,	,	PUNCT
ajlm-916	84	31	and	and	CCONJ
ajlm-916	84	32	contributed	contribute	VERB
ajlm-916	84	33	to	to	ADP
ajlm-916	84	34	the	the	DET
ajlm-916	84	35	initial	initial	ADJ
ajlm-916	84	36	draft	draft	NOUN
ajlm-916	84	37	of	of	ADP
ajlm-916	84	38	the	the	DET
ajlm-916	84	39	article	article	NOUN
ajlm-916	84	40	.	.	PUNCT
ajlm-916	85	1	m.l.s	m.l.s	PROPN
ajlm-916	85	2	.	.	PUNCT
ajlm-916	86	1	and	and	CCONJ
ajlm-916	86	2	m.b	m.b	PROPN
ajlm-916	86	3	.	.	PROPN
ajlm-916	86	4	prepared	prepare	VERB
ajlm-916	86	5	the	the	DET
ajlm-916	86	6	final	final	ADJ
ajlm-916	86	7	manuscript	manuscript	NOUN
ajlm-916	86	8	that	that	PRON
ajlm-916	86	9	was	be	AUX
ajlm-916	86	10	reviewed	review	VERB
ajlm-916	86	11	by	by	ADP
ajlm-916	86	12	all	all	DET
ajlm-916	86	13	authors	author	NOUN
ajlm-916	86	14	.	.	PUNCT
ajlm-916	87	1	sources	source	NOUN
ajlm-916	87	2	of	of	ADP
ajlm-916	87	3	support	support	NOUN
ajlm-916	87	4	this	this	DET
ajlm-916	87	5	investigation	investigation	NOUN
ajlm-916	87	6	was	be	AUX
ajlm-916	87	7	funded	fund	VERB
ajlm-916	87	8	by	by	ADP
ajlm-916	87	9	the	the	DET
ajlm-916	87	10	national	national	PROPN
ajlm-916	87	11	institute	institute	PROPN
ajlm-916	87	12	for	for	ADP
ajlm-916	87	13	communicable	communicable	NOUN
ajlm-916	87	14	diseases	disease	NOUN
ajlm-916	87	15	,	,	PUNCT
ajlm-916	87	16	division	division	NOUN
ajlm-916	87	17	of	of	ADP
ajlm-916	87	18	the	the	DET
ajlm-916	87	19	national	national	PROPN
ajlm-916	87	20	health	health	PROPN
ajlm-916	87	21	laboratory	laboratory	PROPN
ajlm-916	87	22	service	service	PROPN
ajlm-916	87	23	.	.	PUNCT
ajlm-916	88	1	data	datum	NOUN
ajlm-916	88	2	availability	availability	NOUN
ajlm-916	88	3	statement	statement	NOUN
ajlm-916	88	4	data	datum	NOUN
ajlm-916	88	5	sharing	sharing	NOUN
ajlm-916	88	6	is	be	AUX
ajlm-916	88	7	not	not	PART
ajlm-916	88	8	applicable	applicable	ADJ
ajlm-916	88	9	to	to	ADP
ajlm-916	88	10	this	this	DET
ajlm-916	88	11	article	article	NOUN
ajlm-916	88	12	as	as	SCONJ
ajlm-916	88	13	no	no	DET
ajlm-916	88	14	new	new	ADJ
ajlm-916	88	15	data	datum	NOUN
ajlm-916	88	16	were	be	AUX
ajlm-916	88	17	created	create	VERB
ajlm-916	88	18	or	or	CCONJ
ajlm-916	88	19	analysed	analyse	VERB
ajlm-916	88	20	in	in	ADP
ajlm-916	88	21	this	this	DET
ajlm-916	88	22	study	study	NOUN
ajlm-916	88	23	.	.	PUNCT
ajlm-916	89	1	disclaimer	disclaimer	VERB
ajlm-916	89	2	the	the	DET
ajlm-916	89	3	views	view	NOUN
ajlm-916	89	4	and	and	CCONJ
ajlm-916	89	5	opinions	opinion	NOUN
ajlm-916	89	6	expressed	express	VERB
ajlm-916	89	7	in	in	ADP
ajlm-916	89	8	this	this	DET
ajlm-916	89	9	article	article	NOUN
ajlm-916	89	10	are	be	AUX
ajlm-916	89	11	those	those	PRON
ajlm-916	89	12	of	of	ADP
ajlm-916	89	13	the	the	DET
ajlm-916	89	14	authors	author	NOUN
ajlm-916	89	15	and	and	CCONJ
ajlm-916	89	16	do	do	AUX
ajlm-916	89	17	not	not	PART
ajlm-916	89	18	necessarily	necessarily	ADV
ajlm-916	89	19	reflect	reflect	VERB
ajlm-916	89	20	the	the	DET
ajlm-916	89	21	official	official	ADJ
ajlm-916	89	22	policy	policy	NOUN
ajlm-916	89	23	or	or	CCONJ
ajlm-916	89	24	position	position	NOUN
ajlm-916	89	25	of	of	ADP
ajlm-916	89	26	any	any	DET
ajlm-916	89	27	affiliated	affiliated	ADJ
ajlm-916	89	28	agency	agency	NOUN
ajlm-916	89	29	of	of	ADP
ajlm-916	89	30	the	the	DET
ajlm-916	89	31	authors	author	NOUN
ajlm-916	89	32	.	.	PUNCT
ajlm-916	90	1	references	reference	NOUN
ajlm-916	90	2	church	church	NOUN
ajlm-916	90	3	d	d	PROPN
ajlm-916	90	4	,	,	PUNCT
ajlm-916	90	5	elsayed	elsaye	VERB
ajlm-916	90	6	s	s	PROPN
ajlm-916	90	7	,	,	PUNCT
ajlm-916	90	8	reid	reid	PROPN
ajlm-916	90	9	o	o	PROPN
ajlm-916	90	10	,	,	PUNCT
ajlm-916	90	11	winston	winston	PROPN
ajlm-916	90	12	b	b	PROPN
ajlm-916	90	13	,	,	PUNCT
ajlm-916	90	14	lindsay	lindsay	PROPN
ajlm-916	90	15	r.	r.	PROPN
ajlm-916	90	16	burn	burn	VERB
ajlm-916	90	17	wound	wound	NOUN
ajlm-916	90	18	infections	infection	NOUN
ajlm-916	90	19	.	.	PUNCT
ajlm-916	91	1	clin	clin	PROPN
ajlm-916	91	2	microbiol	microbiol	PROPN
ajlm-916	91	3	rev	rev	VERB
ajlm-916	91	4	.	.	PUNCT
ajlm-916	92	1	2006;19(2):403–434	2006;19(2):403–434	X
ajlm-916	92	2	.	.	PUNCT
ajlm-916	92	3	https://doi.org/10.1128/cmr.19.2.403-434.2006	https://doi.org/10.1128/cmr.19.2.403-434.2006	PROPN
ajlm-916	92	4	legrand	legrand	PROPN
ajlm-916	92	5	m	m	PROPN
ajlm-916	92	6	,	,	PUNCT
ajlm-916	92	7	guttormsen	guttormsen	PROPN
ajlm-916	92	8	ab	ab	PROPN
ajlm-916	92	9	,	,	PUNCT
ajlm-916	92	10	berger	berger	PROPN
ajlm-916	92	11	mm	mm	PROPN
ajlm-916	92	12	.	.	PROPN
ajlm-916	92	13	ten	ten	NUM
ajlm-916	92	14	tips	tip	NOUN
ajlm-916	92	15	for	for	ADP
ajlm-916	92	16	managing	manage	VERB
ajlm-916	92	17	critically	critically	ADV
ajlm-916	92	18	ill	ill	ADJ
ajlm-916	92	19	burn	burn	NOUN
ajlm-916	92	20	patients	patient	NOUN
ajlm-916	92	21	:	:	PUNCT
ajlm-916	92	22	follow	follow	VERB
ajlm-916	92	23	the	the	DET
ajlm-916	92	24	rastafari	rastafari	NOUN
ajlm-916	92	25	!	!	PUNCT
ajlm-916	93	1	intensive	intensive	ADJ
ajlm-916	93	2	care	care	NOUN
ajlm-916	93	3	med	me	VERB
ajlm-916	93	4	.	.	PUNCT
ajlm-916	94	1	2015;41(6):1107–1109	2015;41(6):1107–1109	PROPN
ajlm-916	94	2	.	.	PUNCT
ajlm-916	95	1	https://doi.org/10.1007/s00134-014-3627-7	https://doi.org/10.1007/s00134-014-3627-7	PROPN
ajlm-916	96	1	lundy	lundy	PROPN
ajlm-916	96	2	jb	jb	PROPN
ajlm-916	96	3	,	,	PUNCT
ajlm-916	96	4	chung	chung	PROPN
ajlm-916	96	5	kk	kk	PROPN
ajlm-916	96	6	,	,	PUNCT
ajlm-916	96	7	pamplin	pamplin	PROPN
ajlm-916	96	8	jc	jc	PROPN
ajlm-916	96	9	,	,	PUNCT
ajlm-916	96	10	ainsworth	ainsworth	PROPN
ajlm-916	96	11	cr	cr	PROPN
ajlm-916	96	12	,	,	PUNCT
ajlm-916	96	13	jeng	jeng	PROPN
ajlm-916	96	14	jc	jc	PROPN
ajlm-916	96	15	,	,	PUNCT
ajlm-916	96	16	friedman	friedman	PROPN
ajlm-916	96	17	bc	bc	PROPN
ajlm-916	96	18	.	.	PROPN
ajlm-916	96	19	update	update	NOUN
ajlm-916	96	20	on	on	ADP
ajlm-916	96	21	severe	severe	ADJ
ajlm-916	96	22	burn	burn	NOUN
ajlm-916	96	23	management	management	NOUN
ajlm-916	96	24	for	for	ADP
ajlm-916	96	25	the	the	DET
ajlm-916	96	26	intensivist	intensivist	NOUN
ajlm-916	96	27	.	.	PUNCT
ajlm-916	97	1	j	j	PROPN
ajlm-916	97	2	intensive	intensive	ADJ
ajlm-916	97	3	care	care	NOUN
ajlm-916	97	4	med	me	VERB
ajlm-916	97	5	.	.	PUNCT
ajlm-916	98	1	2016;31(8):499–510	2016;31(8):499–510	X
ajlm-916	98	2	.	.	PUNCT
ajlm-916	98	3	https://doi.org/10.1177/0885066615592346	https://doi.org/10.1177/0885066615592346	ADJ
ajlm-916	98	4	wurzer	wurzer	NOUN
ajlm-916	98	5	p	p	NOUN
ajlm-916	98	6	,	,	PUNCT
ajlm-916	98	7	cole	cole	PROPN
ajlm-916	98	8	mr	mr	PROPN
ajlm-916	98	9	,	,	PUNCT
ajlm-916	98	10	clayton	clayton	PROPN
ajlm-916	98	11	rp	rp	PROPN
ajlm-916	98	12	,	,	PUNCT
ajlm-916	98	13	et	et	PROPN
ajlm-916	98	14	al	al	PROPN
ajlm-916	98	15	.	.	PROPN
ajlm-916	98	16	herpesviridae	herpesviridae	VERB
ajlm-916	98	17	infections	infection	NOUN
ajlm-916	98	18	in	in	ADP
ajlm-916	98	19	severely	severely	ADV
ajlm-916	98	20	burned	burn	VERB
ajlm-916	98	21	children	child	NOUN
ajlm-916	98	22	.	.	PUNCT
ajlm-916	99	1	burns	burn	NOUN
ajlm-916	99	2	.	.	PUNCT
ajlm-916	100	1	2017;43(5):987–992	2017;43(5):987–992	X
ajlm-916	100	2	.	.	PUNCT
ajlm-916	101	1	https://doi.org/10.1016/j.burns.2017.01.032	https://doi.org/10.1016/j.burns.2017.01.032	NUM
ajlm-916	101	2	haik	haik	PROPN
ajlm-916	101	3	j	j	PROPN
ajlm-916	101	4	,	,	PUNCT
ajlm-916	101	5	weissman	weissman	PROPN
ajlm-916	101	6	o	o	PROPN
ajlm-916	101	7	,	,	PUNCT
ajlm-916	101	8	stavrou	stavrou	NOUN
ajlm-916	101	9	d	d	PROPN
ajlm-916	101	10	,	,	PUNCT
ajlm-916	101	11	et	et	PROPN
ajlm-916	101	12	al	al	PROPN
ajlm-916	101	13	.	.	PROPN
ajlm-916	101	14	is	be	AUX
ajlm-916	101	15	prophylactic	prophylactic	ADJ
ajlm-916	101	16	acyclovir	acyclovir	PROPN
ajlm-916	101	17	treatment	treatment	NOUN
ajlm-916	101	18	warranted	warrant	VERB
ajlm-916	101	19	for	for	ADP
ajlm-916	101	20	prevention	prevention	NOUN
ajlm-916	101	21	of	of	ADP
ajlm-916	101	22	herpes	herpe	NOUN
ajlm-916	101	23	simplex	simplex	NOUN
ajlm-916	101	24	virus	virus	NOUN
ajlm-916	101	25	infections	infection	NOUN
ajlm-916	101	26	in	in	ADP
ajlm-916	101	27	facial	facial	ADJ
ajlm-916	101	28	burns	burn	NOUN
ajlm-916	101	29	?	?	PUNCT
ajlm-916	102	1	a	a	DET
ajlm-916	102	2	review	review	NOUN
ajlm-916	102	3	of	of	ADP
ajlm-916	102	4	the	the	DET
ajlm-916	102	5	literature	literature	NOUN
ajlm-916	102	6	.	.	PUNCT
ajlm-916	103	1	j	j	PROPN
ajlm-916	103	2	burn	burn	VERB
ajlm-916	103	3	care	care	NOUN
ajlm-916	103	4	res	re	NOUN
ajlm-916	103	5	.	.	PUNCT
ajlm-916	104	1	2011;32(3):358–362	2011;32(3):358–362	NUM
ajlm-916	104	2	.	.	PUNCT
ajlm-916	105	1	https://doi.org/10.1097/bcr.0b013e318217f6de	https://doi.org/10.1097/bcr.0b013e318217f6de	NOUN
ajlm-916	105	2	wurzer	wurzer	NOUN
ajlm-916	105	3	p	p	NOUN
ajlm-916	105	4	,	,	PUNCT
ajlm-916	105	5	guillory	guillory	PROPN
ajlm-916	105	6	a	a	PROPN
ajlm-916	105	7	,	,	PUNCT
ajlm-916	105	8	parvizi	parvizi	NOUN
ajlm-916	105	9	d	d	NOUN
ajlm-916	105	10	,	,	PUNCT
ajlm-916	105	11	et	et	PROPN
ajlm-916	105	12	al	al	PROPN
ajlm-916	105	13	.	.	PUNCT
ajlm-916	106	1	human	human	ADJ
ajlm-916	106	2	herpes	herpe	NOUN
ajlm-916	106	3	viruses	virus	NOUN
ajlm-916	106	4	in	in	ADP
ajlm-916	106	5	burns	burn	NOUN
ajlm-916	106	6	patients	patient	NOUN
ajlm-916	106	7	:	:	PUNCT
ajlm-916	106	8	a	a	DET
ajlm-916	106	9	systematic	systematic	ADJ
ajlm-916	106	10	review	review	NOUN
ajlm-916	106	11	.	.	PUNCT
ajlm-916	107	1	burns	burn	NOUN
ajlm-916	107	2	.	.	PUNCT
ajlm-916	108	1	2017;43(1):25–33	2017;43(1):25–33	NUM
ajlm-916	108	2	.	.	PUNCT
ajlm-916	108	3	https://doi.org/10.1016/j.burns.2016.02.003	https://doi.org/10.1016/j.burns.2016.02.003	PROPN
ajlm-916	108	4	looker	looker	ADP
ajlm-916	108	5	kj	kj	PROPN
ajlm-916	108	6	,	,	PUNCT
ajlm-916	108	7	magaret	magaret	ADJ
ajlm-916	108	8	as	as	ADP
ajlm-916	108	9	,	,	PUNCT
ajlm-916	108	10	may	may	PROPN
ajlm-916	108	11	mt	mt	PROPN
ajlm-916	108	12	,	,	PUNCT
ajlm-916	108	13	et	et	PROPN
ajlm-916	108	14	al	al	PROPN
ajlm-916	108	15	.	.	PROPN
ajlm-916	109	1	global	global	ADJ
ajlm-916	109	2	and	and	CCONJ
ajlm-916	109	3	regional	regional	ADJ
ajlm-916	109	4	estimates	estimate	NOUN
ajlm-916	109	5	of	of	ADP
ajlm-916	109	6	prevalent	prevalent	NOUN
ajlm-916	109	7	and	and	CCONJ
ajlm-916	109	8	incident	incident	NOUN
ajlm-916	109	9	herpes	herpe	NOUN
ajlm-916	109	10	simplex	simplex	NOUN
ajlm-916	109	11	virus	virus	NOUN
ajlm-916	109	12	type	type	VERB
ajlm-916	109	13	1	1	NUM
ajlm-916	109	14	infections	infection	NOUN
ajlm-916	109	15	in	in	ADP
ajlm-916	109	16	2012	2012	NUM
ajlm-916	109	17	.	.	PUNCT
ajlm-916	110	1	plos	plos	PROPN
ajlm-916	110	2	one	one	NUM
ajlm-916	110	3	.	.	PUNCT
ajlm-916	111	1	2015;10(10):e0140765	2015;10(10):e0140765	PROPN
ajlm-916	111	2	.	.	PUNCT
ajlm-916	112	1	https://doi.org/10.1371/journal.pone.0140765	https://doi.org/10.1371/journal.pone.0140765	PROPN
ajlm-916	112	2	hsu	hsu	PROPN
ajlm-916	112	3	ch	ch	PROPN
ajlm-916	112	4	,	,	PUNCT
ajlm-916	112	5	rokini	rokini	ADJ
ajlm-916	112	6	gr	gr	NOUN
ajlm-916	112	7	,	,	PUNCT
ajlm-916	112	8	aghazadeh	aghazadeh	NOUN
ajlm-916	112	9	n	n	CCONJ
ajlm-916	112	10	,	,	PUNCT
ajlm-916	112	11	et	et	PROPN
ajlm-916	112	12	al	al	PROPN
ajlm-916	112	13	.	.	PROPN
ajlm-916	112	14	unique	unique	ADJ
ajlm-916	112	15	presentation	presentation	NOUN
ajlm-916	112	16	of	of	ADP
ajlm-916	112	17	orf	orf	PROPN
ajlm-916	112	18	virus	virus	NOUN
ajlm-916	112	19	infection	infection	NOUN
ajlm-916	112	20	in	in	ADP
ajlm-916	112	21	a	a	DET
ajlm-916	112	22	thermal	thermal	ADJ
ajlm-916	112	23	-	-	PUNCT
ajlm-916	112	24	burn	burn	NOUN
ajlm-916	112	25	patient	patient	NOUN
ajlm-916	112	26	after	after	ADP
ajlm-916	112	27	receiving	receive	VERB
ajlm-916	112	28	an	an	DET
ajlm-916	112	29	autologous	autologous	ADJ
ajlm-916	112	30	skin	skin	NOUN
ajlm-916	112	31	graft	graft	NOUN
ajlm-916	112	32	.	.	PUNCT
ajlm-916	113	1	j	j	PROPN
ajlm-916	113	2	infect	infect	PROPN
ajlm-916	113	3	dis	dis	PROPN
ajlm-916	113	4	.	.	PUNCT
ajlm-916	114	1	2016;214(8):1171–1174	2016;214(8):1171–1174	NUM
ajlm-916	114	2	.	.	PUNCT
ajlm-916	115	1	https://doi.org/10.1093/infdis/jiw307	https://doi.org/10.1093/infdis/jiw307	PROPN
ajlm-916	115	2	gelderblom	gelderblom	PROPN
ajlm-916	115	3	hr	hr	PROPN
ajlm-916	115	4	,	,	PUNCT
ajlm-916	115	5	madeley	madeley	PROPN
ajlm-916	115	6	d.	d.	PROPN
ajlm-916	115	7	rapid	rapid	ADJ
ajlm-916	115	8	viral	viral	ADJ
ajlm-916	115	9	diagnosis	diagnosis	NOUN
ajlm-916	115	10	of	of	ADP
ajlm-916	115	11	orthopoxviruses	orthopoxviruse	NOUN
ajlm-916	115	12	by	by	ADP
ajlm-916	115	13	electron	electron	NOUN
ajlm-916	115	14	microscopy	microscopy	NOUN
ajlm-916	115	15	:	:	PUNCT
ajlm-916	115	16	optional	optional	ADJ
ajlm-916	115	17	or	or	CCONJ
ajlm-916	115	18	a	a	DET
ajlm-916	115	19	must	must	NOUN
ajlm-916	115	20	?	?	PUNCT
ajlm-916	116	1	viruses	virus	NOUN
ajlm-916	116	2	.	.	PUNCT
ajlm-916	117	1	2018;10(4):142	2018;10(4):142	NUM
ajlm-916	117	2	.	.	PUNCT
ajlm-916	118	1	https://doi.org/10.3390/v10040142	https://doi.org/10.3390/v10040142	NUM
ajlm-916	118	2	jugmohan	jugmohan	PROPN
ajlm-916	118	3	b	b	PROPN
ajlm-916	118	4	,	,	PUNCT
ajlm-916	118	5	loveland	loveland	PROPN
ajlm-916	118	6	j	j	PROPN
ajlm-916	118	7	,	,	PUNCT
ajlm-916	118	8	doedens	doeden	VERB
ajlm-916	118	9	l	l	PROPN
ajlm-916	118	10	,	,	PUNCT
ajlm-916	118	11	moore	moore	PROPN
ajlm-916	118	12	rl	rl	PROPN
ajlm-916	118	13	,	,	PUNCT
ajlm-916	118	14	welthagen	welthagen	PROPN
ajlm-916	118	15	a	a	PRON
ajlm-916	118	16	,	,	PUNCT
ajlm-916	118	17	westgarth	westgarth	NOUN
ajlm-916	118	18	-	-	PUNCT
ajlm-916	118	19	taylor	taylor	PROPN
ajlm-916	118	20	cj	cj	PROPN
ajlm-916	118	21	.	.	PUNCT
ajlm-916	119	1	mortality	mortality	NOUN
ajlm-916	119	2	in	in	ADP
ajlm-916	119	3	paediatric	paediatric	ADJ
ajlm-916	119	4	burns	burn	NOUN
ajlm-916	119	5	victims	victim	NOUN
ajlm-916	119	6	:	:	PUNCT
ajlm-916	119	7	a	a	DET
ajlm-916	119	8	retrospective	retrospective	ADJ
ajlm-916	119	9	review	review	NOUN
ajlm-916	119	10	from	from	ADP
ajlm-916	119	11	2009	2009	NUM
ajlm-916	119	12	to	to	ADP
ajlm-916	119	13	2012	2012	NUM
ajlm-916	119	14	in	in	ADP
ajlm-916	119	15	a	a	DET
ajlm-916	119	16	single	single	ADJ
ajlm-916	119	17	centre	centre	NOUN
ajlm-916	119	18	.	.	PUNCT
ajlm-916	120	1	s	s	PROPN
ajlm-916	120	2	afr	afr	PROPN
ajlm-916	120	3	med	med	PROPN
ajlm-916	120	4	j.	j.	PROPN
ajlm-916	120	5	2016;106(2):189–192	2016;106(2):189–192	PROPN
ajlm-916	120	6	.	.	PUNCT
ajlm-916	121	1	https://doi.org/10.7196/samj.2016.v106i2.8942	https://doi.org/10.7196/samj.2016.v106i2.8942	PROPN
ajlm-916	121	2	öncül	öncül	PROPN
ajlm-916	121	3	o	o	NOUN
ajlm-916	121	4	,	,	PUNCT
ajlm-916	121	5	öksüz	öksüz	NOUN
ajlm-916	121	6	s	s	PART
ajlm-916	121	7	,	,	PUNCT
ajlm-916	121	8	acar	acar	VERB
ajlm-916	121	9	a	a	PRON
ajlm-916	121	10	,	,	PUNCT
ajlm-916	121	11	et	et	PROPN
ajlm-916	121	12	al	al	PROPN
ajlm-916	121	13	.	.	PUNCT
ajlm-916	121	14	nosocomial	nosocomial	ADJ
ajlm-916	121	15	infection	infection	NOUN
ajlm-916	121	16	characteristics	characteristic	NOUN
ajlm-916	121	17	in	in	ADP
ajlm-916	121	18	a	a	DET
ajlm-916	121	19	burn	burn	NOUN
ajlm-916	121	20	intensive	intensive	ADJ
ajlm-916	121	21	care	care	NOUN
ajlm-916	121	22	unit	unit	NOUN
ajlm-916	121	23	:	:	PUNCT
ajlm-916	121	24	analysis	analysis	NOUN
ajlm-916	121	25	of	of	ADP
ajlm-916	121	26	an	an	DET
ajlm-916	121	27	eleven	eleven	NUM
ajlm-916	121	28	-	-	PUNCT
ajlm-916	121	29	year	year	NOUN
ajlm-916	121	30	active	active	ADJ
ajlm-916	121	31	surveillance	surveillance	NOUN
ajlm-916	121	32	.	.	PUNCT
ajlm-916	122	1	burns	burn	NOUN
ajlm-916	122	2	.	.	PUNCT
ajlm-916	123	1	2014;40(5):835–841	2014;40(5):835–841	NUM
ajlm-916	123	2	.	.	X
ajlm-916	124	1	https://doi.org/10.1016/j.burns.2013.11.003	https://doi.org/10.1016/j.burns.2013.11.003	NOUN